Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SP2 SP4 ZNF628 ZNF423 DACH1 CC2D1B SIX4 RFX7 FOXA2 FOXJ3 ONECUT1 MEF2A TBX18 JUN FOXP4 EEF1D SALL2 NFE2L1 GLI3 ZNF408 BHLHE22 PITX1 PITX2 HCFC1 EP300	1.27e-06	1244	138	25	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SP2 SP4 ZNF628 ZNF423 DACH1 CC2D1B SIX4 RFX7 FOXA2 FOXJ3 ONECUT1 MEF2A TBX18 JUN FOXP4 EEF1D SALL2 NFE2L1 GLI3 ZNF408 BHLHE22 PITX1 PITX2 HCFC1 EP300	1.86e-06	1271	138	25	GO:0000987
GeneOntologyMolecularFunction	transcription factor binding	CARM1 MED29 APBB1 FOXA2 MEF2A LPIN1 TBX18 JUN EEF1D LATS1 PITX1 PITX2 MED12L KDM1B SPEN HCFC1 EP300 MED13	4.52e-06	753	138	18	GO:0008134
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SP2 SP4 ZNF628 ZNF423 DACH1 CC2D1B STOX1 SIX4 RFX7 FOXA2 FOXJ3 ONECUT1 MEF2A TBX18 JUN FOXP4 EEF1D SALL2 NFE2L1 GLI3 ZNF408 BHLHE22 PITX1 PITX2 HCFC1 EP300	6.81e-06	1459	138	26	GO:0000977
GeneOntologyMolecularFunction	transcription coactivator activity	CARM1 ZXDC BCL9L APBB1 LPIN1 KMT2D RBM14 MED12L HCFC1 EP300 MED13	8.54e-06	303	138	11	GO:0003713
GeneOntologyMolecularFunction	chromatin binding	PCGF2 APBB1 CHD8 FOXA2 ONECUT1 MEF2A PHC2 JUN NFE2L1 ASXL3 GLI3 ATAD2B BHLHE22 PITX2 KDM1B HCFC1 EP300	1.40e-05	739	138	17	GO:0003682
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	CARM1 ZXDC BCL9L GATAD2A MED29 APBB1 SORBS1 WNK1 LPIN1 RGS14 KMT2D DAW1 TNRC6A RBM14 MED12L RACGAP1 CAMTA1 SPEN HCFC1 EP300 MED13 TNS3	1.49e-05	1160	138	22	GO:0030674
GeneOntologyMolecularFunction	beta-catenin binding	CARM1 BCL9L CHD8 AJAP1 GLI3 MED12L EP300	2.01e-05	120	138	7	GO:0008013
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SP2 SP4 ZNF628 ZNF423 DACH1 CC2D1B SIX4 RFX7 FOXA2 FOXJ3 ONECUT1 MEF2A TBX18 JUN FOXP4 KMT2D SALL2 NFE2L1 GLI3 ZNF408 BHLHE22 PITX1 PITX2 ZNF292	3.52e-05	1412	138	24	GO:0000981
GeneOntologyMolecularFunction	transcription coregulator activity	CARM1 ZXDC BCL9L MED29 APBB1 LPIN1 KMT2D RBM14 MED12L CAMTA1 SPEN HCFC1 EP300 MED13	3.58e-05	562	138	14	GO:0003712
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	CARM1 APBB1 MEF2A LPIN1 TBX18 JUN EEF1D LATS1 PITX1 PITX2 SPEN HCFC1 EP300 MED13	5.22e-05	582	138	14	GO:0140297
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	ZNF628 SIX4 FOXA2 FOXJ3 ONECUT1 MEF2A JUN KMT2D SALL2 NFE2L1 PITX1 PITX2 ZNF292	1.39e-04	560	138	13	GO:0001228
GeneOntologyMolecularFunction	RNA uridylyltransferase activity	TUT4 TUT7	1.42e-04	3	138	2	GO:0050265
GeneOntologyMolecularFunction	molecular adaptor activity	CARM1 ZXDC BCL9L GATAD2A MED29 APBB1 SORBS1 WNK1 LPIN1 RGS14 KMT2D DAW1 TNRC6A RBM14 MED12L RACGAP1 CAMTA1 SPEN HCFC1 EP300 MED13 TNS3	1.53e-04	1356	138	22	GO:0060090
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	ZNF628 SIX4 FOXA2 FOXJ3 ONECUT1 MEF2A JUN KMT2D SALL2 NFE2L1 PITX1 PITX2 ZNF292	1.55e-04	566	138	13	GO:0001216
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	LPIN1 ASXL3 EP300	3.92e-04	21	138	3	GO:0042975
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	MEF2A LPIN1 TBX18 JUN LATS1 PITX1 PITX2 SPEN EP300 MED13	6.52e-04	417	138	10	GO:0061629
GeneOntologyMolecularFunction	uridylyltransferase activity	TUT4 TUT7	9.73e-04	7	138	2	GO:0070569
GeneOntologyMolecularFunction	histone acetyltransferase binding	MEF2A KANSL1 GLI3	1.03e-03	29	138	3	GO:0035035
GeneOntologyMolecularFunction	acetylation-dependent protein binding	CARM1 ATAD2B EP300	1.26e-03	31	138	3	GO:0140033
GeneOntologyMolecularFunction	extracellular matrix binding	ZAN SPOCK2 ADAMTS5 LTBP2	1.64e-03	73	138	4	GO:0050840
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	SP2 DACH1 CC2D1B TBX18 JUN FOXP4 NFE2L1 PITX2	1.75e-03	320	138	8	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	SP2 DACH1 CC2D1B TBX18 JUN FOXP4 NFE2L1 PITX2	1.96e-03	326	138	8	GO:0001217
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	CARM1 BCL9L MED29 APBB1 CHD8 SIX4 RFX7 FOXA2 FOXJ3 ONECUT1 MEF2A KANSL3 LPIN1 JUN EEF1D KMT2D SALL2 NFE2L1 ASXL3 GLI3 BHLHE22 PITX1 PITX2 RBM14 MED12L HLTF CAMTA1 HCFC1 EP300 MED13 ZNF292	2.53e-09	1390	139	31	GO:0045944
GeneOntologyBiologicalProcess	embryo development	SP2 PCGF2 MAN2A1 GATAD2A AFF3 CHD8 TNRC6C STOX1 SIX4 FOXA2 WNK1 TBX18 FOXP4 PHLDB1 KMT2D LATS1 SALL2 CELF1 GLI3 PITX1 PITX2 RBM14 ANKRD11 RACGAP1 MYO18B HCFC1 EP300 CNOT3	2.93e-07	1437	139	28	GO:0009790
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	SP2 PCGF2 GATAD2A SCAF8 ZNF423 APBB1 DACH1 CC2D1B CHD8 ZNF318 SIX4 MEF2A PHC2 LPIN1 TBX18 JUN FOXP4 SALL2 NFE2L1 GLI3 BHLHE22 PITX1 PITX2 SPEN SAP130 HCFC1 EP300	6.00e-07	1399	139	27	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	SP2 PCGF2 GATAD2A SCAF8 ZNF423 APBB1 DACH1 CC2D1B CHD8 ZNF318 SIX4 MEF2A PHC2 LPIN1 TBX18 JUN FOXP4 SALL2 NFE2L1 GLI3 BHLHE22 PITX1 PITX2 SPEN SAP130 HCFC1 EP300	7.28e-07	1413	139	27	GO:1902679
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	SP2 PCGF2 GATAD2A SCAF8 APBB1 DACH1 CC2D1B CHD8 MEF2A LPIN1 TBX18 JUN FOXP4 SALL2 NFE2L1 GLI3 PITX2 SPEN SAP130 HCFC1 EP300	7.77e-06	1053	139	21	GO:0000122
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	SP2 PCGF2 MAN2A1 GATAD2A CHD8 SIX4 FOXA2 TBX18 KMT2D LATS1 SALL2 CELF1 GLI3 PITX2 ANKRD11 MYO18B HCFC1 EP300 CNOT3	1.56e-05	929	139	19	GO:0009792
GeneOntologyBiologicalProcess	embryonic morphogenesis	PCGF2 GATAD2A AFF3 TNRC6C STOX1 SIX4 FOXA2 WNK1 TBX18 FOXP4 PHLDB1 LATS1 GLI3 PITX1 PITX2 RBM14	2.55e-05	713	139	16	GO:0048598
GeneOntologyBiologicalProcess	chordate embryonic development	SP2 PCGF2 MAN2A1 GATAD2A CHD8 SIX4 FOXA2 TBX18 KMT2D LATS1 SALL2 GLI3 PITX2 ANKRD11 MYO18B HCFC1 EP300 CNOT3	3.88e-05	906	139	18	GO:0043009
GeneOntologyBiologicalProcess	respiratory system development	SPRY1 MAN2A1 TNRC6C SIX4 FOXA2 FOXP4 GLI3 PITX2 EP300 TNS3	4.28e-05	305	139	10	GO:0060541
GeneOntologyBiologicalProcess	in utero embryonic development	SP2 PCGF2 MAN2A1 GATAD2A CHD8 FOXA2 KMT2D LATS1 GLI3 PITX2 ANKRD11 MYO18B HCFC1 CNOT3	5.17e-05	596	139	14	GO:0001701
GeneOntologyBiologicalProcess	lung development	SPRY1 MAN2A1 TNRC6C FOXA2 FOXP4 GLI3 PITX2 EP300 TNS3	8.94e-05	269	139	9	GO:0030324
GeneOntologyBiologicalProcess	respiratory tube development	SPRY1 MAN2A1 TNRC6C FOXA2 FOXP4 GLI3 PITX2 EP300 TNS3	1.00e-04	273	139	9	GO:0030323
GeneOntologyBiologicalProcess	cell fate commitment	GATAD2A FOXA2 ONECUT1 TBX18 LATS1 NFE2L1 GLI3 BHLHE22 PITX1 EP300	1.01e-04	338	139	10	GO:0045165
GeneOntologyBiologicalProcess	transforming growth factor beta receptor signaling pathway	BCL9L SPRY1 TNRC6C ONECUT1 JUN LATS1 LTBP2 SAP130 EP300	1.09e-04	276	139	9	GO:0007179
GeneOntologyBiologicalProcess	latent virus replication	JUN HCFC1	1.35e-04	3	139	2	GO:0019045
GeneOntologyBiologicalProcess	release from viral latency	JUN HCFC1	1.35e-04	3	139	2	GO:0019046
GeneOntologyBiologicalProcess	polyuridylation-dependent mRNA catabolic process	TUT4 TUT7	1.35e-04	3	139	2	GO:1990074
GeneOntologyBiologicalProcess	transforming growth factor beta receptor superfamily signaling pathway	BCL9L SPRY1 ZNF423 SPART TNRC6C ONECUT1 JUN LATS1 LTBP2 SAP130 EP300	2.19e-04	445	139	11	GO:0141091
GeneOntologyBiologicalProcess	regulation of termination of RNA polymerase II transcription	SCAF8 WNK1	2.68e-04	4	139	2	GO:1904594
GeneOntologyBiologicalProcess	cardiac cell development	SPRY1 MEF2A TBX18 PITX2 MYO18B EP300	2.75e-04	132	139	6	GO:0055006
GeneOntologyBiologicalProcess	miRNA processing	TUT4 TUT7 NUP155 PUM1	3.05e-04	48	139	4	GO:0035196
GeneOntologyBiologicalProcess	chromatin organization	CARM1 PCGF2 GATAD2A APBB1 CHD8 FOXA2 KANSL3 KMT2D KANSL2 KANSL1 ATAD2B RBM14 HLTF KDM1B HCFC1 EP300	3.59e-04	896	139	16	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	CARM1 PCGF2 GATAD2A MED29 APBB1 CHD8 FOXA2 KANSL3 KMT2D KANSL2 KANSL1 ATAD2B RBM14 HLTF KDM1B HCFC1 EP300	4.06e-04	999	139	17	GO:0071824
GeneOntologyBiologicalProcess	cell surface receptor protein serine/threonine kinase signaling pathway	BCL9L SPRY1 ZNF423 SPART TNRC6C ONECUT1 JUN LATS1 LTBP2 SAP130 EP300	4.31e-04	482	139	11	GO:0007178
GeneOntologyBiologicalProcess	transposable element silencing by mRNA destabilization	TUT4 TUT7	4.45e-04	5	139	2	GO:0141008
GeneOntologyBiologicalProcess	RNA 3' uridylation	TUT4 TUT7	4.45e-04	5	139	2	GO:0071076
GeneOntologyBiologicalProcess	cellular response to transforming growth factor beta stimulus	BCL9L SPRY1 TNRC6C ONECUT1 JUN LATS1 LTBP2 SAP130 EP300	4.66e-04	336	139	9	GO:0071560
GeneOntologyCellularComponent	transcription regulator complex	CARM1 BCL9L GATAD2A MED29 DACH1 SIX4 FOXA2 MEF2A LPIN1 TBX18 JUN GLI3 PITX1 PITX2 RBM14 HLTF SPEN EP300	8.09e-08	596	138	18	GO:0005667
GeneOntologyCellularComponent	NSL complex	KANSL3 KANSL2 KANSL1 HCFC1	5.79e-07	11	138	4	GO:0044545
GeneOntologyCellularComponent	chromatin	SP2 SP4 PCGF2 GATAD2A CHD8 SIX4 RFX7 FOXA2 FOXJ3 ONECUT1 MEF2A PHC2 KANSL3 TBX18 JUN FOXP4 KANSL2 KANSL1 NFE2L1 BHLHE22 PITX1 PITX2 ANKRD11 KDM1B SAP130 HCFC1 EP300	1.19e-06	1480	138	27	GO:0000785
GeneOntologyCellularComponent	nuclear protein-containing complex	CARM1 SEH1L BCL9L PCGF2 GATAD2A MED29 SCAF8 AFF3 CHD8 PHC2 TBX18 JUN KMT2D KANSL1 NUP155 ASXL3 NABP2 MED12L HLTF SRRM2 SAP130 UVRAG HCFC1 MED13	1.11e-05	1377	138	24	GO:0140513
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	KANSL3 KANSL2 KANSL1 HCFC1	2.20e-04	45	138	4	GO:1902562
GeneOntologyCellularComponent	histone acetyltransferase complex	KANSL3 KANSL2 KANSL1 HCFC1 EP300	4.00e-04	94	138	5	GO:0000123
GeneOntologyCellularComponent	P-body	UBAP2 TNRC6C TNRC6A PUM1 CNOT3	5.81e-04	102	138	5	GO:0000932
GeneOntologyCellularComponent	protein acetyltransferase complex	KANSL3 KANSL2 KANSL1 HCFC1 EP300	6.35e-04	104	138	5	GO:0031248
GeneOntologyCellularComponent	acetyltransferase complex	KANSL3 KANSL2 KANSL1 HCFC1 EP300	7.86e-04	109	138	5	GO:1902493
GeneOntologyCellularComponent	MLL1 complex	CHD8 KANSL1 HCFC1	1.21e-03	32	138	3	GO:0071339
GeneOntologyCellularComponent	MLL1/2 complex	CHD8 KANSL1 HCFC1	1.33e-03	33	138	3	GO:0044665
GeneOntologyCellularComponent	histone methyltransferase complex	CHD8 KMT2D KANSL1 HCFC1	1.54e-03	75	138	4	GO:0035097
GeneOntologyCellularComponent	mediator complex	MED29 MED12L MED13	1.86e-03	37	138	3	GO:0016592
HumanPheno	Thin upper lip vermilion	PCGF2 AFF3 RFX7 B4GALT1 SYNGAP1 KMT2D ASXL3 PITX2 MED12L ANKRD11 TRAPPC10 CEP152 MYO18B SRRM2 SPEN EP300 MED13 ZNF292	1.62e-08	339	58	18	HP:0000219
HumanPheno	Thin lips	PCGF2 AFF3 RFX7 B4GALT1 SYNGAP1 KMT2D ASXL3 PITX2 MED12L ANKRD11 TRAPPC10 CEP152 MYO18B SRRM2 SPEN EP300 MED13 ZNF292	1.62e-08	339	58	18	HP:0000213
HumanPheno	Thin vermilion border	PCGF2 AFF3 RFX7 B4GALT1 SYNGAP1 KMT2D ASXL3 PITX2 MED12L ANKRD11 TRAPPC10 CEP152 CAMTA1 MYO18B SRRM2 SPEN EP300 MED13 ZNF292	1.29e-07	433	58	19	HP:0000233
HumanPheno	Abnormality of upper lip vermillion	PCGF2 AFF3 CHD8 RFX7 B4GALT1 SYNGAP1 KMT2D ASXL3 PITX2 MED12L ANKRD11 TRAPPC10 CEP152 MYO18B SRRM2 SPEN EP300 MED13 ZNF292	3.87e-07	464	58	19	HP:0011339
HumanPheno	Abnormal upper lip morphology	PCGF2 AFF3 CHD8 RFX7 FOXA2 B4GALT1 SYNGAP1 KMT2D KANSL1 ASXL3 GLI3 PITX1 DHODH PITX2 MED12L ANKRD11 TRAPPC10 CEP152 CAMTA1 MYO18B SRRM2 SPEN EP300 CNOT3 MED13 ZNF292	7.00e-06	980	58	26	HP:0000177
HumanPheno	Abnormal location of ears	PCGF2 ZNF423 AFF3 SPART CHD8 RFX7 B4GALT1 SYNGAP1 KMT2D KANSL1 ASXL3 GLI3 PITX1 DHODH CEP41 ANKRD11 CEP152 CAMTA1 MYO18B PUM1 SRRM2 SPEN EP300 CNOT3 ZNF292	1.25e-05	945	58	25	HP:0000357
HumanPheno	Abnormality of the chin	PCGF2 AFF3 CHD8 RFX7 KMT2D KANSL1 ASXL3 MED12L ANKRD11 CAMTA1 PUM1 SRRM2 SPEN CNOT3 ZNF292	3.42e-05	409	58	15	HP:0000306
HumanPheno	Abnormality of the palpebral fissures	PCGF2 AFF3 SPART CHD8 RFX7 SYNGAP1 KMT2D KANSL1 ASXL3 GLI3 PITX1 DHODH MED12L ANKRD11 TRAPPC10 CEP152 CAMTA1 PUM1 SPEN EP300 CNOT3 MED13 ZNF292	4.23e-05	880	58	23	HP:0008050
HumanPheno	Bulbous nose	AFF3 KMT2D KANSL1 ASXL3 MED12L CAMTA1 MYO18B SRRM2 SPEN ZNF292	7.28e-05	201	58	10	HP:0000414
HumanPheno	Abnormal external nose morphology	PCGF2 ZNF423 AFF3 RFX7 FOXA2 SYNGAP1 KMT2D KANSL1 COG6 ASXL3 GLI3 CEP41 MED12L ANKRD11 CEP152 CAMTA1 MYO18B PUM1 SRRM2 SPEN EP300 CNOT3 ZNF292	8.11e-05	916	58	23	HP:0010938
HumanPheno	Slanting of the palpebral fissure	PCGF2 SPART CHD8 RFX7 SYNGAP1 KMT2D KANSL1 ASXL3 GLI3 PITX1 DHODH MED12L ANKRD11 TRAPPC10 CEP152 CAMTA1 SPEN EP300 CNOT3 ZNF292	1.05e-04	739	58	20	HP:0200006
HumanPheno	Prominent fingertip pads	KMT2D KANSL1 MED12L EP300 ZNF292	1.54e-04	46	58	5	HP:0001212
HumanPheno	Prominent digit pad	KMT2D KANSL1 MED12L EP300 ZNF292	1.89e-04	48	58	5	HP:0011298
HumanPheno	Abnormal lip morphology	PCGF2 AFF3 CHD8 RFX7 FOXA2 B4GALT1 SYNGAP1 KMT2D KANSL1 COG6 ASXL3 GLI3 PITX1 DHODH PITX2 MED12L ANKRD11 TRAPPC10 CEP152 CAMTA1 MYO18B SRRM2 SPEN EP300 CNOT3 MED13 ZNF292	1.98e-04	1249	58	27	HP:0000159
HumanPheno	Generalized myoclonic-atonic seizure	SYNGAP1 CAMTA1 MED13	2.17e-04	11	58	3	HP:0011170
HumanPheno	Abnormal nasal tip morphology	PCGF2 AFF3 RFX7 KMT2D KANSL1 COG6 ASXL3 MED12L CAMTA1 MYO18B SRRM2 SPEN ZNF292	3.01e-04	386	58	13	HP:0000436
HumanPheno	Prominent nasal bridge	ZNF423 KANSL1 ASXL3 CEP41 MED12L ANKRD11 CEP152 PUM1 SPEN MED13	3.05e-04	239	58	10	HP:0000426
HumanPheno	Downslanted palpebral fissures	PCGF2 SPART CHD8 SYNGAP1 KMT2D ASXL3 GLI3 PITX1 DHODH MED12L ANKRD11 CEP152 CAMTA1 SPEN EP300	3.16e-04	497	58	15	HP:0000494
HumanPheno	Autistic behavior	PCGF2 ZNF423 AFF3 CHD8 RFX7 SYNGAP1 KMT2D KANSL1 ASXL3 MED12L ANKRD11 CAMTA1 SRRM2 SPEN EP300 CNOT3 MED13 ZNF292	3.41e-04	678	58	18	HP:0000729
HumanPheno	Chronic constipation	PCGF2 AFF3 SPART CAMTA1 EP300 MED13 ZNF292	3.75e-04	120	58	7	HP:0012450
HumanPheno	Diagnostic behavioral phenotype	PCGF2 ZNF423 AFF3 CHD8 RFX7 SYNGAP1 KMT2D KANSL1 ASXL3 MED12L ANKRD11 CAMTA1 SRRM2 SPEN USH2A EP300 CNOT3 MED13 ZNF292	3.83e-04	747	58	19	HP:0025783
HumanPheno	Low hanging columella	AFF3 KMT2D ASXL3 PUM1 EP300	3.94e-04	56	58	5	HP:0009765
HumanPheno	Hip dysplasia	KMT2D KANSL1 COG6 GLI3 DHODH ANKRD11 CEP152 SPEN EP300 CNOT3	3.98e-04	247	58	10	HP:0001385
Domain	RRM	PTBP3 SCAF8 RBMS2 SRSF11 TNRC6C CELF1 TNRC6A RBM14 SPEN	3.84e-05	217	140	9	SM00360
Domain	RRM_dom	PTBP3 SCAF8 RBMS2 SRSF11 TNRC6C CELF1 TNRC6A RBM14 SPEN	5.45e-05	227	140	9	IPR000504
Domain	M_domain	TNRC6C TNRC6A	5.58e-05	2	140	2	PF12938
Domain	GW182_M_dom	TNRC6C TNRC6A	5.58e-05	2	140	2	IPR026805
Domain	RRM	PTBP3 SCAF8 RBMS2 SRSF11 TNRC6C CELF1 TNRC6A RBM14 SPEN	6.03e-05	230	140	9	PS50102
Domain	Nucleotide-bd_a/b_plait	PTBP3 SCAF8 RBMS2 SRSF11 TNRC6C CELF1 TNRC6A RBM14 SPEN	1.45e-04	258	140	9	IPR012677
Domain	Ago_hook	TNRC6C TNRC6A	1.67e-04	3	140	2	PF10427
Domain	TNRC6_PABC-bd	TNRC6C TNRC6A	1.67e-04	3	140	2	IPR032226
Domain	Argonaute_hook_dom	TNRC6C TNRC6A	1.67e-04	3	140	2	IPR019486
Domain	TNRC6-PABC_bdg	TNRC6C TNRC6A	1.67e-04	3	140	2	PF16608
Domain	Homeobox_Pitx/unc30	PITX1 PITX2	1.67e-04	3	140	2	IPR016233
Domain	RRM_1	PTBP3 SCAF8 RBMS2 SRSF11 TNRC6C CELF1 RBM14 SPEN	1.76e-04	208	140	8	PF00076
Domain	-	PTBP3 SCAF8 RBMS2 SRSF11 TNRC6C CELF1 TNRC6A SPEN	5.14e-04	244	140	8	3.30.70.330
Domain	tRNA-bd_arm	KRT3 CEP152 CNOT3	7.43e-04	24	140	3	IPR010978
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KANSL3 KMT2D KANSL2 KANSL1 HCFC1	4.99e-06	38	94	5	MM17073
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KANSL3 KMT2D KANSL2 KANSL1 HCFC1	8.29e-06	42	94	5	M48018
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	CARM1 GATAD2A KANSL3 KMT2D KANSL2 KANSL1 KDM1B SAP130 HCFC1 EP300	1.32e-05	272	94	10	M29619
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	CARM1 GATAD2A KANSL3 KMT2D KANSL2 KANSL1 KDM1B HCFC1	2.16e-05	175	94	8	MM14941
Pathway	KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119	PCGF2 PHC2 ASXL3 HCFC1	2.48e-05	26	94	4	M47923
Pathway	REACTOME_ADIPOGENESIS	CARM1 GATAD2A MED29 ZNF423 EP300 MED13	9.18e-05	110	94	6	M48259
Pathway	REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	TNRC6C TNRC6A KDM1B EP300	1.03e-04	37	94	4	M29790
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	TUT4 TUT7 EP300	1.82e-04	17	94	3	M48025
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	KANSL3 KANSL2 KANSL1 HCFC1	2.44e-04	46	94	4	MM14935
Pathway	REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	TNRC6C TNRC6A KDM1B EP300	2.66e-04	47	94	4	M29777
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	SEH1L PCGF2 PHC2 NUP155	2.66e-04	47	94	4	M27395
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	GATAD2A KANSL3 KMT2D KANSL2 KANSL1 SAP130 HCFC1 EP300	2.91e-04	254	94	8	M27131
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	KANSL3 KMT2D KANSL2 KANSL1 HCFC1 EP300	2.93e-04	136	94	6	MM14848
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	KANSL3 KANSL2 KANSL1 SAP130 HCFC1 EP300	3.70e-04	142	94	6	M27233
Pathway	WP_ENDODERM_DIFFERENTIATION	SP4 TNRC6C RFX7 FOXA2 ONECUT1 NABP2	3.84e-04	143	94	6	M39591
Pathway	REACTOME_DEADENYLATION_OF_MRNA	TUT4 TUT7 CNOT3	5.94e-04	25	94	3	M13492
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	SEH1L PCGF2 PHC2 NUP155	5.97e-04	58	94	4	MM15149
Pathway	BIOCARTA_CARM_ER_PATHWAY	CARM1 SPEN EP300	6.68e-04	26	94	3	M2499
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	BCL9L KMT2D EP300	6.68e-04	26	94	3	MM14793
Pubmed	Human transcription factor protein interaction networks.	BCL9L SP2 UBAP2 DDX31 GATAD2A ACACB SCAF8 SEC24A DACH1 CHD8 ZNF318 TNRC6C SIX4 RFX7 MEF2A KANSL3 JUN TIMM8A FOXP4 EEF1D KMT2D KANSL2 SALL2 KANSL1 GLI3 PITX1 TNRC6A RACGAP1 CEP152 USP54 KDM1B PUM1 SRRM2 SPEN SAP130 HCFC1 EP300 CNOT3	6.02e-21	1429	140	38	35140242
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SEH1L SP2 GATAD2A MED29 SRSF11 ZNF318 SIX4 RFX7 PHC2 KANSL3 JUN TIMM8A KMT2D KANSL2 KANSL1 CELF1 USP42 PITX1 RBM14 ANKRD11 HLTF RACGAP1 DCLRE1A NKTR KDM1B SRRM2 SPEN SAP130 HCFC1 EP300	5.90e-15	1294	140	30	30804502
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PHACTR2 UBAP2 SEC24A AAK1 APBB1 SRSF11 SORBS1 RFX7 MAST2 WNK1 PHLDB1 LATS1 RBM14 ANKRD11 RACGAP1 CEP152 USP54 CRYBG3 PPIP5K2 PUM1 SRRM2 UVRAG TNS3	7.25e-13	861	140	23	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ZXDC ABCA2 ZNF628 CHD8 TNRC6C MAST2 WNK1 PHC2 KANSL3 ORAI1 JUN PHLDB1 KMT2D KANSL1 ZNF408 PITX1 USP40 ANKRD11 PCNX1 PUM1 SPEN UVRAG HCFC1 EP300 MED13	2.48e-12	1105	140	25	35748872
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	GATAD2A DACH1 SIX4 FOXA2 FOXJ3 MEF2A KANSL3 JUN FOXP4 EEF1D KMT2D KANSL2 SALL2 KANSL1 PITX2 KDM1B PUM1 SPEN SAP130 HCFC1 EP300	3.95e-11	857	140	21	25609649
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	CARM1 BCL9L SCAF8 SEC24A RBMS2 PON2 FOXA2 B4GALT1 KMT2D NUP155 MEIOC TNRC6A RBM14 PUM1 SAP130 EP300	5.86e-11	457	140	16	32344865
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SEH1L SP4 GATAD2A MED29 DACH1 CHD8 ZNF318 FOXJ3 MEF2A KANSL3 JUN EEF1D KMT2D CELF1 PITX1 RBM14 HLTF SRRM2 SPEN SAP130 HCFC1 EP300 ZNF292	1.04e-10	1103	140	23	34189442
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SP4 UBAP2 ACACB TSPOAP1 TSC22D2 WNK1 FOXJ3 SYNGAP1 LATS1 NUP155 NFE2L1 CAMTA1 SPEN SAP130 UVRAG	2.53e-10	430	140	15	35044719
Pubmed	A census of human transcription factors: function, expression and evolution.	SP2 SP4 TSC22D2 SIX4 RFX7 FOXA2 FOXJ3 ONECUT1 MEF2A TBX18 JUN FOXP4 KMT2D SALL2 NFE2L1 GLI3 BHLHE22 PITX1 PITX2 CAMTA1	7.63e-10	908	140	20	19274049
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TSPOAP1 SCAF8 ZNF423 SPOCK2 SORBS1 TNRC6C PHLDB1 KANSL1 NAV3 CAMTA1 PUM1 SRRM2 SPEN SEZ6L	1.24e-09	407	140	14	12693553
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	DACH1 SIX4 JUN KMT2D SPEN SAP130 EP300 ZNF292	1.72e-09	83	140	8	28794006
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9L ACACB ZNF423 CHD8 SIX4 RFX7 FOXP4 KMT2D ASXL3 PITX1 PITX2 SPEN EP300	2.05e-09	351	140	13	38297188
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SCAF8 AAK1 ZNF318 RFX7 PHC2 KANSL3 JUN KMT2D KANSL2 LATS1 KANSL1 USP42 RBM14 TRAPPC10 SRRM2 SPEN CNOT3 MED13	2.49e-09	774	140	18	15302935
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	CARM1 PTBP3 SP2 DDX31 GATAD2A ACACB SCAF8 SRSF11 CHD8 KANSL3 EEF1D CELF1 MEIOC USP42 TNRC6A HLTF CRYBG1 NKTR PPIP5K2 PUM1 SRRM2 SAP130 HCFC1	3.18e-09	1318	140	23	30463901
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	KRT3 GATAD2A SEC24A APBB1 CHD8 SIX4 KANSL3 JUN CELF1 RACGAP1 CRYBG3 SRRM2 SAP130 TNS3	8.15e-09	472	140	14	38943005
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SEC24A APBB1 ZNF318 NUP155 MEIOC GLI3 TNRC6A RBM14 TMEM131 USP54 CRYBG3	1.08e-08	263	140	11	34702444
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	CARM1 ZXDC PCGF2 GATAD2A PHC2 KANSL3 TIMM8A KMT2D KANSL2 KANSL1 RBM14 KDM1B HCFC1 ZNF292	1.48e-08	495	140	14	27705803
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	GATAD2A MED29 KANSL3 FOXP4 KMT2D SALL2 RBM14 HCFC1 MED13	2.79e-08	167	140	9	20362541
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZXDC SP2 PCGF2 TUT7 ZNF318 SIX4 FOXJ3 ONECUT1 MEF2A JUN FOXP4 SALL2 NFE2L1 GLI3 PITX2 ZNF292	3.09e-08	709	140	16	22988430
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ABCA2 UBAP2 AAK1 SPART CHD8 FOXJ3 KANSL3 NUP155 TNRC6A MED12L RACGAP1 PCNX1 PPIP5K2 MED13	3.38e-08	529	140	14	14621295
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	GATAD2A ZNF423 SRSF11 SORBS1 FOXJ3 KANSL1 CELF1 TNRC6A ANKRD11 CEP152 CAMTA1 PPIP5K2 PUM1 MED13	3.98e-08	536	140	14	15840001
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PTBP3 TUT4 UBAP2 RBMS2 AAK1 SPART CELF1 TNRC6A RBM14 RACGAP1 DCLRE1A TMEM131 PUM1 SPEN TNS3 ZNF292	4.12e-08	724	140	16	36232890
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	GATAD2A ZNF423 SRSF11 SORBS1 FOXJ3 KANSL1 CELF1 TNRC6A ANKRD11 CEP152 CAMTA1 PPIP5K2 PUM1 MED13	4.17e-08	538	140	14	10512203
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TUT4 UBAP2 SCAF8 TUT7 SHC4 WNK1 TNRC6A RACGAP1 DCLRE1A TMEM131 PRR14L USP54 PPIP5K2 PUM1 HCFC1 TNS3	4.88e-08	733	140	16	34672954
Pubmed	Crosstalk between NSL histone acetyltransferase and MLL/SET complexes: NSL complex functions in promoting histone H3K4 di-methylation activity by MLL/SET complexes.	KANSL3 KANSL2 KANSL1 HCFC1	5.18e-08	10	140	4	24244196
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	UBAP2 GATAD2A RBMS2 DACH1 SRSF11 CHD8 ZNF318 JUN EEF1D ATAD2B RBM14 ANKRD11 RACGAP1 PUM1 SRRM2 SPEN SAP130 HCFC1	6.08e-08	954	140	18	36373674
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ACACB SEC24A TUT7 AAK1 SORBS1 TNRC6C MAST2 LATS1 MEIOC TNRC6A CEP41 RBM14 TMEM131 CEP152 USP54 PPIP5K2 BORA	6.70e-08	853	140	17	28718761
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	CARM1 PTBP3 SEH1L TUT4 APBB1 SPART TNRC6C CELF1 MEIOC TNRC6A USP54	8.48e-08	322	140	11	39098523
Pubmed	Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex.	KANSL3 KANSL2 KANSL1 HCFC1	1.21e-07	12	140	4	20018852
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9L CHD8 MEF2A KANSL3 JUN FOXP4 KMT2D SAP130 HCFC1 MED13	1.49e-07	268	140	10	33640491
Pubmed	MOF-associated complexes ensure stem cell identity and Xist repression.	KANSL3 KANSL2 KANSL1 HCFC1	1.75e-07	13	140	4	24842875
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	CARM1 PTBP3 SCAF8 RBMS2 SRSF11 TNRC6C CELF1 TNRC6A RBM14 PUM1 SPEN	1.80e-07	347	140	11	16033648
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZXDC SP2 SP4 ZNF423 TUT7 ZNF318 SIX4 FOXJ3 ONECUT1 MEF2A JUN NFE2L1 GLI3 PITX2 HLTF ZNF292	1.83e-07	808	140	16	20412781
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TNRC6C RFX7 FOXJ3 JUN PITX2 TNRC6A RBM14 EP300	2.03e-07	152	140	8	38360978
Pubmed	Males absent on the first (MOF): from flies to humans.	KANSL3 KANSL2 KANSL1	2.55e-07	4	140	3	17694080
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	PCGF2 GATAD2A CHD8 PHC2 KMT2D ANKRD11 KDM1B EP300	2.60e-07	157	140	8	30186101
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	SP2 GATAD2A AAK1 DACH1 SPART CHD8 ZNF318 KANSL3 EEF1D SALL2 CELF1 HCFC1	2.70e-07	444	140	12	34795231
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SCAF8 TUT7 CC2D1B SRSF11 CHD8 MAST2 LPIN1 NUP155 RBM14 HLTF RACGAP1 CRYBG3 PPIP5K2 HCFC1	4.14e-07	650	140	14	38777146
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	CHD8 MAST2 LPIN1 NFE2L1 GLI3 HLTF USP54 PUM1 BORA	4.60e-07	232	140	9	25515538
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	PTBP3 UBAP2 GATAD2A PON2 SPART NUP155 COG6 HLTF RACGAP1 PUM1 SAP130 HCFC1 CNOT3	4.75e-07	560	140	13	35241646
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SP2 PCGF2 DACH1 TBX18 JUN NFE2L1 GLI3 ZNF408 PITX2 RBM14 HLTF SPEN HCFC1 EP300 CNOT3 ZNF292	5.42e-07	877	140	16	20211142
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	BCL9L ACACB SCAF8 SPART RFX7 NUP155 TNRC6A RBM14	7.35e-07	180	140	8	35198878
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ABCA2 SPOCK2 SORBS1 MAST2 FOXJ3 CEP152 MED13	1.03e-06	130	140	7	12421765
Pubmed	Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression.	MEF2A JUN EP300	1.27e-06	6	140	3	20590529
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MAST2 LPIN1 SALL2 COG6 TMEM131 ZNF292	1.48e-06	87	140	6	12465718
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	PTBP3 SPRY1 PHACTR2 ZNF423 TUT7 AFF3 CC2D1B SRSF11 CHD8 MAST2 SYNGAP1 TIMM8A EEF1D CEP152 USP54 PUM1 EP300 MED13	2.02e-06	1215	140	18	15146197
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	BCL9L ACACB SORBS1 MAST2 WNK1 LATS1 TNRC6A TRAPPC10 CEP152 USP54 PUM1	2.10e-06	446	140	11	24255178
Pubmed	Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila.	KANSL3 KANSL2 KANSL1	2.21e-06	7	140	3	16543150
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	SP2 SIX4 RFX7 FOXA2 FOXJ3 ONECUT1 TBX18 JUN GLI3 BHLHE22 PITX1 PITX2	2.26e-06	544	140	12	28473536
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SP2 GATAD2A CHD8 PHC2 FOXP4 GLI3 SPEN SAP130 CNOT3	2.31e-06	282	140	9	23667531
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	PTBP3 SP2 GATAD2A ACACB AAK1 CHD8 PHC2 FOXP4 NUP155 CNOT3	2.77e-06	370	140	10	22922362
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	SPRY1 GATAD2A ACACB SEC24A APBB1 SPART PHC2 JUN EEF1D LATS1 SALL2 CELF1 CEP41 RBM14 RACGAP1 TMEM131	3.24e-06	1007	140	16	34597346
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SEC24A RBMS2 AAK1 TNRC6C WNK1 MEF2A LPIN1 PHLDB1 PITX1 CEP41 CRYBG1 PUM1 UVRAG CNOT3 TNS3 BORA	4.75e-06	1038	140	16	26673895
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DDX31 SPART SORBS1 ZNF318 WNK1 KANSL3 SALL2 TNRC6A RBM14 CRYBG3 SPEN CNOT3	4.99e-06	588	140	12	38580884
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	UBAP2 SPART SRSF11 ZNF318 WNK1 EEF1D CELF1 SRRM2 SAP130 HCFC1	5.39e-06	399	140	10	35987950
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	MEF2A JUN RBM14 SPEN UVRAG TNS3	5.80e-06	110	140	6	37219487
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	SP2 ZNF628 GATAD2A RBMS2 JUN GLI3 RBM14 RACGAP1 MED13	6.61e-06	321	140	9	32098917
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	GATAD2A ZNF423 CHD8 PHC2 EEF1D SALL2 RBM14 SRRM2 HCFC1 EP300	6.98e-06	411	140	10	35182466
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	DDX31 GATAD2A CHD8 FOXJ3 ATAD2B PITX1 HLTF RACGAP1 KDM1B SPEN HCFC1 ZNF292	6.99e-06	608	140	12	36089195
Pubmed	Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.	CHD8 KMT2D KANSL1 HCFC1	7.27e-06	31	140	4	15960975
Pubmed	miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT.	TNRC6C TNRC6A CNOT3	7.50e-06	10	140	3	21984185
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TUT4 SCAF8 AFF3 AAK1 PON2 SRSF11 TNRC6C FOXJ3 MEF2A B4GALT1 KANSL3 FOXP4 PHLDB1 USP40 ANKRD11 CAMTA1 AADAT SAP130 EP300	8.82e-06	1489	140	19	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	BCL9L DDX31 MAN2A1 SCAF8 AAK1 CHD8 ZNF318 SIX4 FOXJ3 PHC2 ORAI1 TNRC6A ANKRD11 HLTF CRYBG1 KDM1B SPEN CNOT3 MED13	9.51e-06	1497	140	19	31527615
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	GATAD2A CHD8 ZNF318 SALL2 NFE2L1 RACGAP1 SPEN SAP130 HCFC1	1.02e-05	339	140	9	30415952
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SCAF8 ZNF318 KMT2D TNRC6A DCLRE1A CEP152 SPEN	1.03e-05	184	140	7	32908313
Pubmed	Neural metabolic imbalance induced by MOF dysfunction triggers pericyte activation and breakdown of vasculature.	KANSL3 KANSL2 KANSL1	1.03e-05	11	140	3	32541879
Pubmed	miRNA repression involves GW182-mediated recruitment of CCR4-NOT through conserved W-containing motifs.	TNRC6C TNRC6A CNOT3	1.03e-05	11	140	3	21984184
Pubmed	The SIL gene is required for mouse embryonic axial development and left-right specification.	FOXA2 GLI3 PITX2	1.03e-05	11	140	3	10385121
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	GATAD2A ACACB GOLGA6L2 APBB1 PON2 FOXJ3 LMOD2 PHLDB1 KMT2D ASXL3 SPEN EP300	1.13e-05	638	140	12	31182584
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TUT4 GATAD2A CHD8 ZNF318 MAST2 FOXP4 SALL2 GLI3 TNRC6A USP54 CRYBG3 KDM1B SRRM2 SAP130 EP300 SEZ6L	1.17e-05	1116	140	16	31753913
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	UBAP2 APBB1 DACH1 CHD8 ZNF318 KMT2D LATS1 SPEN SAP130 HCFC1 EP300	1.49e-05	549	140	11	38280479
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	GATAD2A CHD8 ZAP70 EEF1D RBM14 HLTF SPEN	1.50e-05	195	140	7	19454010
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CARM1 GATAD2A MED29 CHD8 PHC2 KANSL3 EEF1D NUP155 RBM14 HLTF KDM1B SAP130 HCFC1 EP300 MED13	1.55e-05	1014	140	15	32416067
Pubmed	The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases.	FOXA2 ONECUT1	1.61e-05	2	140	2	17283222
Pubmed	Otlx2, an Otx-related homeobox gene expressed in the pituitary gland and in a restricted pattern in the forebrain.	PITX1 PITX2	1.61e-05	2	140	2	9026314
Pubmed	Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely independent of Foxa2.	FOXA2 ONECUT1	1.61e-05	2	140	2	16055718
Pubmed	Pathogenic variants in EP300 and ANKRD11 in patients with phenotypes overlapping Cornelia de Lange syndrome.	ANKRD11 EP300	1.61e-05	2	140	2	32476269
Pubmed	TUT4/7-mediated uridylation of a coronavirus subgenomic RNAs delays viral replication.	TUT4 TUT7	1.61e-05	2	140	2	37085578
Pubmed	A common intermediary factor (p52/54) recognizing "acidic blob"-type domains is required for transcriptional activation by the Jun proteins.	JUN HCFC1	1.61e-05	2	140	2	1448082
Pubmed	Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis.	MEF2A CELF1	1.61e-05	2	140	2	14722059
Pubmed	Pitx genes during cardiovascular development.	PITX1 PITX2	1.61e-05	2	140	2	12858527
Pubmed	TUT7 controls the fate of precursor microRNAs by using three different uridylation mechanisms.	TUT4 TUT7	1.61e-05	2	140	2	25979828
Pubmed	An epigenetic regulator emerges as microtubule minus-end binding and stabilizing factor in mitosis.	KANSL3 KANSL1	1.61e-05	2	140	2	26243146
Pubmed	Cell-specific activation of the atrial natriuretic factor promoter by PITX2 and MEF2A.	MEF2A PITX2	1.61e-05	2	140	2	15466416
Pubmed	A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.	JUN EP300	1.61e-05	2	140	2	11689449
Pubmed	The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses.	TUT4 TUT7	1.61e-05	2	140	2	28665939
Pubmed	RNA uridyl transferases TUT4/7 differentially regulate miRNA variants depending on the cancer cell type.	TUT4 TUT7	1.61e-05	2	140	2	34949722
Pubmed	FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.	FOXA2 JUN	1.61e-05	2	140	2	38851846
Pubmed	Beta-1,4-galactosyltransferase and alpha-mannosidase-II messenger ribonucleic acid levels increase with different kinetics in thyrotrophs of hypothyroid mice.	MAN2A1 B4GALT1	1.61e-05	2	140	2	7956920
Pubmed	Inhibition of the liver enriched protein FOXA2 recovers HNF6 activity in human colon carcinoma and liver hepatoma cells.	FOXA2 ONECUT1	1.61e-05	2	140	2	20967225
Pubmed	Uridylation by TUT4 and TUT7 marks mRNA for degradation.	TUT4 TUT7	1.61e-05	2	140	2	25480299
Pubmed	Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells.	CARM1 EP300	1.61e-05	2	140	2	32650558
Pubmed	Terminal Uridylyltransferases TUT4/7 Regulate microRNA and mRNA Homeostasis.	TUT4 TUT7	1.61e-05	2	140	2	36497000
Pubmed	Expression of the members of the Ptx family of transcription factors in human pituitary adenomas.	PITX1 PITX2	1.61e-05	2	140	2	10372733
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	BCL9L SRSF11 MAST2 PHLDB1 ASXL3 MYO18B SRRM2 SPEN TNS3	1.68e-05	361	140	9	26167880
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ABCA2 PCGF2 ZNF423 APBB1 SPOCK2 SORBS1 SYNGAP1 KANSL2 NABP2 NAV3 TMEM131 USP54 EP300 CNOT3 MED13 SEZ6L ZNF292	1.73e-05	1285	140	17	35914814
Pubmed	Ftm is a novel basal body protein of cilia involved in Shh signalling.	FOXA2 GLI3 PITX2	1.77e-05	13	140	3	17553904
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	TUT4 TNRC6C TNRC6A PUM1 CNOT3	1.86e-05	80	140	5	35803934
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BCL9L GATAD2A CHD8 KMT2D CELF1 USP42 TNRC6A CRYBG1 SPEN HCFC1	2.18e-05	469	140	10	27634302
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	PTBP3 TUT4 DDX31 RBMS2 TUT7 SRSF11 JUN CELF1 TNRC6A RBM14 PUM1 SRRM2 SPEN	2.47e-05	807	140	13	22681889
Interaction	YWHAH interactions	ABCA2 PHACTR2 UBAP2 SEC24A AAK1 APBB1 SORBS1 RFX7 MAST2 WNK1 SYNGAP1 JUN PHLDB1 LATS1 RBM14 ANKRD11 TRAPPC10 RACGAP1 DCLRE1A CEP152 NKTR USP54 CRYBG3 PPIP5K2 PUM1 SRRM2 UVRAG TNS3	1.41e-09	1102	138	28	int:YWHAH
Interaction	NUP43 interactions	SEH1L BCL9L DDX31 GATAD2A ACACB CHD8 ZNF318 KANSL3 KMT2D SALL2 KANSL1 ATAD2B RBM14 ANKRD11 HLTF NKTR SRRM2 SPEN HCFC1 ZNF292	9.98e-09	625	138	20	int:NUP43
Interaction	EYA4 interactions	SEH1L AAK1 TNRC6C SIX4 RFX7 FOXJ3 JUN NUP155 PITX2 TNRC6A RBM14 PPIP5K2 EP300	1.28e-08	243	138	13	int:EYA4
Interaction	R3HDM2 interactions	SPRY1 TUT4 UBAP2 RBMS2 TNRC6C CELF1 TNRC6A USP54 PUM1 CNOT3	2.01e-08	129	138	10	int:R3HDM2
Interaction	NUP35 interactions	SEH1L BCL9L SCAF8 SEC24A RBMS2 PON2 FOXA2 KMT2D NUP155 MEIOC TNRC6A RBM14 TACR3 PUM1 SAP130 EP300	3.57e-08	424	138	16	int:NUP35
Interaction	SMG7 interactions	SCAF8 DACH1 CHD8 ZNF318 TNRC6C SIX4 KMT2D LATS1 SALL2 CELF1 TNRC6A CEP152 PUM1 CNOT3	4.21e-08	319	138	14	int:SMG7
Interaction	TOP3B interactions	ZXDC ABCA2 UBAP2 ZNF628 SEC24A CHD8 TNRC6C MAST2 WNK1 PHC2 KANSL3 ORAI1 JUN PHLDB1 KMT2D KANSL1 CELF1 ZNF408 PITX1 USP40 RBM14 ANKRD11 RACGAP1 PCNX1 PUM1 SPEN UVRAG HCFC1 EP300 MED13	5.08e-08	1470	138	30	int:TOP3B
Interaction	TNRC6A interactions	GATAD2A TNRC6C WNK1 LATS1 NUP155 CELF1 GLI3 TNRC6A CEP152 USP54 PUM1 CNOT3 MED13	6.84e-08	280	138	13	int:TNRC6A
Interaction	TNRC6B interactions	CARM1 SEC24A TNRC6C EEF1D LATS1 NUP155 CELF1 GLI3 TNRC6A CEP152 USP54 PUM1 CNOT3	7.43e-08	282	138	13	int:TNRC6B
Interaction	RBBP5 interactions	GATAD2A ACACB CHD8 KANSL3 KMT2D KANSL2 KANSL1 TNRC6A HLTF SRRM2 SPEN HCFC1 EP300	9.11e-08	287	138	13	int:RBBP5
Interaction	SEC24B interactions	CARM1 MAN2A1 SEC24A AAK1 TNRC6C B4GALT1 LATS1 NUP155 TNRC6A TRAPPC10 PPIP5K2 EP300	1.00e-07	240	138	12	int:SEC24B
Interaction	DCAF4 interactions	PTBP3 TUT4 ACACB RBMS2 TUT7 TNRC6C LPIN1 CELF1 TNRC6A RBM14 USP54 SRRM2 SPEN EP300	3.37e-07	378	138	14	int:DCAF4
Interaction	FAM120C interactions	PTBP3 TUT4 RBMS2 TNRC6C NUP155 CELF1 TNRC6A USP54 PUM1 CNOT3	7.99e-07	191	138	10	int:FAM120C
Interaction	SOX2 interactions	PTBP3 BCL9L SP2 PCGF2 GATAD2A RBMS2 TUT7 DACH1 CHD8 SIX4 MAST2 MEF2A PHC2 JUN FOXP4 KMT2D SALL2 GLI3 PITX1 TNRC6A RBM14 NAV3 SPEN SAP130 EP300 CNOT3 ZNF292	1.11e-06	1422	138	27	int:SOX2
Interaction	YWHAG interactions	PHACTR2 UBAP2 SEC24A AAK1 APBB1 SRSF11 SORBS1 RFX7 MAST2 WNK1 SYNGAP1 LPIN1 PHLDB1 LATS1 RBM14 ANKRD11 TRAPPC10 RACGAP1 NKTR USP54 PPIP5K2 PUM1 SRRM2 UVRAG TNS3	1.14e-06	1248	138	25	int:YWHAG
Interaction	CPEB4 interactions	TUT4 UBAP2 TNRC6C CELF1 TNRC6A RBM14 USP54 PUM1 CNOT3	1.30e-06	156	138	9	int:CPEB4
Interaction	RNF43 interactions	CARM1 SEC24A RBMS2 APBB1 ZNF318 NUP155 MEIOC USP42 GLI3 TNRC6A RBM14 TMEM131 USP54 CRYBG3	1.44e-06	427	138	14	int:RNF43
Interaction	RBMS1 interactions	PTBP3 TUT4 UBAP2 RBMS2 CELF1 NABP2 TNRC6A HLTF PUM1 CNOT3	1.66e-06	207	138	10	int:RBMS1
Interaction	CEP85 interactions	TNRC6C LATS1 NUP155 CELF1 GLI3 TNRC6A CEP152 PUM1 CNOT3	2.52e-06	169	138	9	int:CEP85
Interaction	PPIA interactions	KRT3 GATAD2A SEC24A APBB1 CHD8 SIX4 SYNGAP1 KANSL3 JUN TIMM8A PHLDB1 CELF1 RACGAP1 CRYBG3 SRRM2 SAP130 UVRAG HCFC1 CNOT3 TNS3	2.72e-06	888	138	20	int:PPIA
Interaction	FOXK2 interactions	KANSL3 KMT2D KANSL2 CD6 KANSL1 ASXL3 KDM1B SAP130 HCFC1 EP300	3.51e-06	225	138	10	int:FOXK2
Interaction	PUM1 interactions	PTBP3 TUT4 UBAP2 RBMS2 TNRC6C LATS1 CELF1 TNRC6A PUM1 EP300 CNOT3	4.69e-06	287	138	11	int:PUM1
Interaction	ALG13 interactions	SCAF8 RBMS2 KMT2D LATS1 CELF1 PITX1 TNRC6A PUM1 EP300	4.83e-06	183	138	9	int:ALG13
Interaction	TNRC6C interactions	SEC24A TNRC6C LATS1 CELF1 TNRC6A USP54 PUM1 CNOT3	4.95e-06	138	138	8	int:TNRC6C
Interaction	CEP192 interactions	SEH1L TNRC6C LATS1 NUP155 USP42 TNRC6A CEP152 KDM1B PPIP5K2	7.14e-06	192	138	9	int:CEP192
Interaction	DAZL interactions	PTBP3 TUT4 UBAP2 RBMS2 CELF1 TNRC6A PUM1 CNOT3	7.14e-06	145	138	8	int:DAZL
Interaction	EGLN3 interactions	CARM1 SEH1L TUT4 UBAP2 SCAF8 SEC24A APBB1 CHD8 ZNF318 LPIN1 JUN PHLDB1 GLI3 PITX1 ANKRD11 RACGAP1 TMEM131 PRR14L USP54 PPIP5K2 PUM1 HCFC1 CNOT3 BORA	7.39e-06	1296	138	24	int:EGLN3
Interaction	TLE3 interactions	BCL9L SCAF8 SEC24A ZNF318 SIX4 KMT2D TNRC6A RBM14 SRRM2 SPEN SAP130 EP300	1.10e-05	376	138	12	int:TLE3
Interaction	SYNE3 interactions	SEC24A SORBS1 ZNF318 TNRC6C LATS1 NUP155 GLI3 TNRC6A TMEM131 CEP152 USP54 CRYBG3 PUM1	1.18e-05	444	138	13	int:SYNE3
Interaction	CEBPA interactions	SEH1L SP4 GATAD2A MED29 DACH1 CHD8 ZNF318 FOXJ3 MEF2A KANSL3 JUN EEF1D KMT2D CELF1 PITX1 RBM14 HLTF SRRM2 SPEN SAP130 HCFC1 EP300 ZNF292	1.23e-05	1245	138	23	int:CEBPA
Interaction	CNOT3 interactions	UBAP2 TNRC6C GLI3 TNRC6A TMEM131 CEP152 PUM1 EP300 CNOT3	1.31e-05	207	138	9	int:CNOT3
Interaction	ZYX interactions	AAK1 SPART SORBS1 TSC22D2 WNK1 LATS1 TNRC6A RACGAP1 CEP152 CRYBG3 EP300	1.69e-05	329	138	11	int:ZYX
Interaction	WDR5 interactions	CARM1 ZXDC SEH1L UBAP2 MAN2A1 ACACB CHD8 KANSL3 EEF1D KMT2D KANSL2 KANSL1 NUP155 ASXL3 PITX2 TNRC6A RBM14 RACGAP1 KDM1B HCFC1 EP300	1.92e-05	1101	138	21	int:WDR5
Interaction	H2BC21 interactions	PCGF2 GATAD2A GOLGA6L2 CC2D1B CHD8 PHC2 USP42 NABP2 HLTF RACGAP1 CRYBG1 KDM1B SRRM2 HCFC1 EP300 ZNF292	2.30e-05	696	138	16	int:H2BC21
Interaction	PCGF6 interactions	PCGF2 APBB1 PHC2 KANSL3 TIMM8A KANSL2 LATS1 KANSL1	2.37e-05	171	138	8	int:PCGF6
Interaction	TERF2IP interactions	GATAD2A DACH1 SRSF11 CHD8 ZNF318 KANSL3 SALL2 ANKRD11 RACGAP1 SRRM2 SPEN SAP130 HCFC1 ZNF292	2.66e-05	552	138	14	int:TERF2IP
Interaction	GSC interactions	BCL9L FOXA2 FOXP4 KMT2D ASXL3 EP300	2.96e-05	87	138	6	int:GSC
Interaction	CELF1 interactions	PTBP3 TUT4 UBAP2 SCAF8 RBMS2 SRSF11 TNRC6C CELF1 TNRC6A PUM1	3.01e-05	288	138	10	int:CELF1
Interaction	PHF20 interactions	CHD8 KANSL3 KANSL2 KANSL1 HCFC1	3.09e-05	53	138	5	int:PHF20
Interaction	CNOT9 interactions	UBAP2 SCAF8 ZNF318 TNRC6C TNRC6A TMEM131 CEP152 PUM1 CNOT3	3.11e-05	231	138	9	int:CNOT9
Interaction	BUB3 interactions	BTBD10 KANSL3 JUN KMT2D KANSL2 KANSL1 ASXL3 HCFC1 EP300	3.22e-05	232	138	9	int:BUB3
Interaction	HCFC1 interactions	CHD8 KANSL3 JUN EEF1D KMT2D KANSL2 KANSL1 NFE2L1 ASXL3 HCFC1	3.48e-05	293	138	10	int:HCFC1
Interaction	CXXC1 interactions	KANSL3 KMT2D KANSL2 KANSL1 ZNF408 HCFC1 EP300	3.50e-05	132	138	7	int:CXXC1
Interaction	KMT2C interactions	KANSL3 JUN KMT2D ASXL3 TNRC6A KDM1B HCFC1	3.86e-05	134	138	7	int:KMT2C
Interaction	FUBP3 interactions	TUT4 RBMS2 TNRC6C CELF1 TNRC6A RBM14 USP54 PUM1 EP300 CNOT3	3.90e-05	297	138	10	int:FUBP3
Interaction	ATN1 interactions	KANSL3 KANSL2 KANSL1 PITX1 PITX2 RBM14 USP54 HCFC1	4.49e-05	187	138	8	int:ATN1
Interaction	SP7 interactions	BCL9L SCAF8 ZNF318 SIX4 MEF2A FOXP4 KMT2D PITX1 SAP130 EP300	4.75e-05	304	138	10	int:SP7
Interaction	ASF1A interactions	GATAD2A CHD8 JUN KMT2D SALL2 SPEN SAP130 HCFC1 EP300	5.58e-05	249	138	9	int:ASF1A
Interaction	SMAD3 interactions	DACH1 CHD8 PHC2 JUN CD6 KANSL1 GLI3 PITX1 PITX2 RBM14 SAP130 EP300	5.99e-05	447	138	12	int:SMAD3
Interaction	CPEB1 interactions	UBAP2 TNRC6C JUN TNRC6A USP54 PUM1 CNOT3	6.66e-05	146	138	7	int:CPEB1
Interaction	MEX3A interactions	BCL9L DDX31 CHD8 JUN CELF1 NFE2L1 ANKRD11 PUM1 EP300 CNOT3 TNS3	6.91e-05	384	138	11	int:MEX3A
Interaction	MKRN2 interactions	CARM1 PTBP3 RBMS2 TUT7 TNRC6C CELF1 GLI3 TNRC6A PUM1 EP300 CNOT3	7.07e-05	385	138	11	int:MKRN2
Interaction	NR2C2 interactions	CARM1 PTBP3 SP2 DDX31 GATAD2A ACACB SCAF8 SRSF11 CHD8 KANSL3 EEF1D CELF1 MEIOC USP42 TNRC6A HLTF CRYBG1 NKTR PPIP5K2 PUM1 SRRM2 SAP130 HCFC1	7.90e-05	1403	138	23	int:NR2C2
Interaction	SFN interactions	AAK1 ZC2HC1C SORBS1 MAST2 WNK1 PHLDB1 LATS1 RBM14 RACGAP1 USP54 CRYBG3 PUM1 SRRM2 SAP130 TNS3	8.16e-05	692	138	15	int:SFN
Interaction	ASH2L interactions	CHD8 KANSL3 KMT2D KANSL2 KANSL1 TNRC6A HCFC1 EP300 ZNF292	8.99e-05	265	138	9	int:ASH2L
Interaction	DTX2 interactions	BCL9L ACACB SCAF8 SPART RFX7 NUP155 TNRC6A RBM14 HLTF USP54	9.39e-05	330	138	10	int:DTX2
Interaction	BAG2 interactions	PTBP3 TUT4 UBAP2 AAK1 ZNF318 WNK1 SALL2 PRR14L PPIP5K2 PUM1 SRRM2 SPEN EP300 CNOT3	9.61e-05	622	138	14	int:BAG2
Interaction	EN1 interactions	DACH1 JUN KMT2D SRRM2 SAP130 EP300	1.10e-04	110	138	6	int:EN1
Interaction	HNF4A interactions	DACH1 FOXA2 KANSL3 KMT2D KANSL2 KANSL1 SPEN SAP130 EP300	1.19e-04	275	138	9	int:HNF4A
Interaction	TBR1 interactions	BCL9L FOXP4 KMT2D LATS1 PITX1 EP300	1.28e-04	113	138	6	int:TBR1
Interaction	MEX3B interactions	TUT4 UBAP2 RBMS2 TNRC6C TNRC6A USP54 PUM1 CNOT3	1.49e-04	222	138	8	int:MEX3B
Interaction	AR interactions	BCL9L KRT3 SHC4 CHD8 ZNF318 MEF2A KANSL3 JUN FOXP4 KMT2D GLI3 RBM14 MED12L USP54 SAP130 HCFC1 EP300 MED13	1.50e-04	992	138	18	int:AR
Interaction	CNOT8 interactions	TNRC6C TNRC6A TMEM131 PUM1 CNOT3	1.54e-04	74	138	5	int:CNOT8
Interaction	SETD1B interactions	KANSL3 KMT2D KANSL2 KANSL1 HCFC1	1.64e-04	75	138	5	int:SETD1B
Interaction	PHF20L1 interactions	GATAD2A KANSL3 KANSL2 KANSL1 HCFC1	1.64e-04	75	138	5	int:PHF20L1
Interaction	SMC5 interactions	UBAP2 GATAD2A RBMS2 DACH1 SRSF11 CHD8 ZNF318 JUN EEF1D ATAD2B RBM14 ANKRD11 RACGAP1 PUM1 SRRM2 SPEN SAP130 HCFC1	1.65e-04	1000	138	18	int:SMC5
Interaction	BICD2 interactions	AAK1 ZC2HC1C SORBS1 MAST2 COG6 TNRC6A CEP41 TMEM131 USP54 PPIP5K2 BORA	1.72e-04	426	138	11	int:BICD2
Interaction	SETD1A interactions	CHD8 KANSL3 KMT2D KANSL2 KANSL1 HCFC1 EP300	1.72e-04	170	138	7	int:SETD1A
Interaction	NFIX interactions	DACH1 SIX4 KANSL3 JUN KMT2D KANSL2 SPEN SAP130	1.73e-04	227	138	8	int:NFIX
Interaction	FOXP3 interactions	PTBP3 SP2 GATAD2A ACACB AAK1 CHD8 PHC2 FOXP4 NUP155 EP300 CNOT3	1.94e-04	432	138	11	int:FOXP3
Interaction	H3-3A interactions	CARM1 GATAD2A CHD8 FOXJ3 KMT2D ATAD2B PITX1 HLTF RACGAP1 KDM1B SPEN SAP130 HCFC1 EP300 ZNF292	1.94e-04	749	138	15	int:H3-3A
Interaction	YWHAB interactions	SEC24A AAK1 SORBS1 RFX7 MAST2 WNK1 PHLDB1 LATS1 RBM14 TRAPPC10 RACGAP1 USP54 PPIP5K2 PUM1 SRRM2 SAP130 UVRAG TNS3	1.96e-04	1014	138	18	int:YWHAB
Interaction	HDAC1 interactions	C2orf69 GATAD2A ACACB ZNF423 APBB1 DACH1 CHD8 ZNF318 MEF2A JUN KMT2D GLI3 PITX2 TNRC6A CRYBG3 SPEN SAP130 HCFC1 EP300	2.01e-04	1108	138	19	int:HDAC1
Interaction	PAX7 interactions	DACH1 SIX4 FOXP4 KMT2D SAP130 EP300	2.13e-04	124	138	6	int:PAX7
Interaction	UBAP2L interactions	TUT4 UBAP2 RBMS2 TNRC6C CELF1 TNRC6A PUM1 HCFC1 CNOT3	2.17e-04	298	138	9	int:UBAP2L
Interaction	ZBTB7B interactions	SP2 ZNF628 GATAD2A RBMS2 JUN GLI3 RBM14 RACGAP1 EP300 MED13	2.18e-04	366	138	10	int:ZBTB7B
Interaction	MIR143 interactions	PTBP3 TUT4 CELF1 RBM14 PUM1	2.23e-04	80	138	5	int:MIR143
Interaction	CNOT2 interactions	UBAP2 TNRC6C KANSL3 TNRC6A TMEM131 PUM1 CNOT3	2.28e-04	178	138	7	int:CNOT2
Interaction	SOX7 interactions	FOXP4 KMT2D RBM14 EP300 ZNF292	2.50e-04	82	138	5	int:SOX7
Interaction	NFE2L1 interactions	JUN CD6 NFE2L1 HCFC1	2.52e-04	45	138	4	int:NFE2L1
Interaction	ZFP36 interactions	TUT4 RBMS2 TNRC6C TNRC6A USP54 PUM1 CNOT3	2.53e-04	181	138	7	int:ZFP36
Interaction	DYNLT1 interactions	AAK1 CHD8 ZNF318 PITX2 RBM14 SPEN SAP130 HCFC1	2.60e-04	241	138	8	int:DYNLT1
Interaction	ARL16 interactions	ZNF318 TNRC6A RBM14 DCLRE1A SPEN	2.65e-04	83	138	5	int:ARL16
Interaction	KMT2B interactions	KANSL3 KMT2D KANSL2 KANSL1 TNRC6A HCFC1	2.75e-04	130	138	6	int:KMT2B
Interaction	B4GALT1 interactions	CARM1 SEC24A PON2 B4GALT1 EP300	2.80e-04	84	138	5	int:B4GALT1
Interaction	ASB3 interactions	ZNF318 ZAP70 FOXP4 SALL2 USP54	2.80e-04	84	138	5	int:ASB3
Interaction	CDC16 interactions	ZNF318 SALL2 ZNF408 DHODH TNRC6A PRR14L USP54 EP300	2.99e-04	246	138	8	int:CDC16
Interaction	YTHDF3 interactions	TUT4 UBAP2 RBMS2 TNRC6C CELF1 TNRC6A PUM1 CNOT3	2.99e-04	246	138	8	int:YTHDF3
Interaction	YTHDF2 interactions	TUT4 UBAP2 RBMS2 TNRC6C CELF1 GLI3 TNRC6A PUM1 CNOT3	3.05e-04	312	138	9	int:YTHDF2
Interaction	MYB interactions	DACH1 KANSL3 KMT2D KANSL1 EP300 ZNF292	3.11e-04	133	138	6	int:MYB
Interaction	MED13 interactions	MED29 TSC22D2 TNRC6A MED12L MED13	3.13e-04	86	138	5	int:MED13
Interaction	NINL interactions	TNRC6C JUN LATS1 KANSL1 MEIOC ZNF408 TNRC6A TMEM131 CEP152 USP54 CNOT3	3.20e-04	458	138	11	int:NINL
Interaction	MEF2D interactions	CARM1 MEF2A JUN KMT2D EP300	3.30e-04	87	138	5	int:MEF2D
Interaction	TRAPPC5 interactions	CARM1 MAN2A1 SEC24A B4GALT1 TRAPPC10 EP300	3.37e-04	135	138	6	int:TRAPPC5
Interaction	QKI interactions	CARM1 MED29 RBMS2 CELF1 TNRC6A RBM14 MED13	3.40e-04	190	138	7	int:QKI
Interaction	MAX interactions	CHD8 JUN EEF1D KMT2D LATS1 SAP130 HCFC1 EP300	3.42e-04	251	138	8	int:MAX
Interaction	C9orf78 interactions	PTBP3 UBAP2 GATAD2A PON2 SPART NUP155 COG6 HLTF RACGAP1 PUM1 SAP130 HCFC1 CNOT3	3.42e-04	620	138	13	int:C9orf78
Interaction	MIR138-2 interactions	PTBP3 TUT7 CELF1 RBM14 PUM1	3.48e-04	88	138	5	int:MIR138-2
Interaction	UFSP1 interactions	COG6 PITX1 PITX2 RBM14	3.51e-04	49	138	4	int:UFSP1
Interaction	MIR92A2 interactions	PTBP3 RBMS2 CELF1 RBM14 PUM1	3.86e-04	90	138	5	int:MIR92A2
Cytoband	17q22-q23	TSPOAP1 MED13	1.37e-04	6	140	2	17q22-q23
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC6C KMT2D BHLHE22 TNRC6A	8.31e-06	25	95	4	775
GeneFamily	Beta-gamma crystallin domain containing	CRYBG1 CRYBG3	8.17e-05	3	95	2	1360
GeneFamily	RNA binding motif containing	PTBP3 SCAF8 RBMS2 SRSF11 CELF1 RBM14 SPEN	1.31e-04	213	95	7	725
GeneFamily	Non-canonical poly(A) polymerases	TUT4 TUT7	5.64e-04	7	95	2	1318
GeneFamily	Cyclins\|Mediator complex	MED29 MED12L MED13	6.84e-04	33	95	3	1061
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP2 SP4	9.60e-04	9	95	2	755
GeneFamily	Forkhead boxes	FOXA2 FOXJ3 FOXP4	1.49e-03	43	95	3	508
GeneFamily	Ubiquitin specific peptidases	USP42 USP40 USP54	3.18e-03	56	95	3	366
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZXDC SP2 SP4 ZNF628 ZNF423 ZNF318 SALL2 GLI3 ZNF408 ZNF292	4.43e-03	718	95	10	28
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TUT4 UBAP2 RFX7 MAST2 WNK1 KANSL1 ATAD2B MED12L PRR14L HCFC1 EP300 MED13	2.58e-10	180	140	12	M8239
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TUT4 MAN2A1 SCAF8 SEC24A SPART TSC22D2 MAST2 FOXJ3 MEF2A JUN ATAD2B NAV3 HLTF TMEM131 CRYBG3 PPIP5K2 PUM1 SPEN UVRAG MED13 ZNF292	5.90e-09	856	140	21	M4500
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PTBP3 TUT4 SCAF8 AAK1 SPOCK2 TNRC6C RFX7 WNK1 FOXJ3 ZAP70 LPIN1 RGS14 EEF1D KMT2D LATS1 CD6 KANSL1 CELF1 USP42 ANKRD11 TRAPPC10 CRYBG1 PCNX1 SPEN EP300 MED13 ZNF292	2.11e-08	1492	140	27	M40023
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	CARM1 ZXDC SP2 TUT4 AAK1 SPOCK2 MEF2A LPIN1 ANKRD11 TMEM131 NKTR PUM1 SRRM2 SPEN HCFC1 EP300	3.03e-07	634	140	16	M40866
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	PCGF2 ACACB TUT7 PON2 FOXJ3 MEF2A KANSL3 JUN NUP155 CELF1 ZNF408 SEZ6L	9.46e-07	378	140	12	M41174
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TUT4 MAN2A1 SCAF8 SEC24A FOXJ3 JUN ATAD2B TMEM131 PUM1 SPEN UVRAG MED13 ZNF292	1.39e-06	466	140	13	M13522
Coexpression	GABRIELY_MIR21_TARGETS	PTBP3 PHACTR2 SRSF11 RFX7 WNK1 LPIN1 LATS1 ATAD2B CRYBG1 ZNF292	3.70e-06	289	140	10	M2196
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	TUT4 AAK1 SPOCK2 FOXJ3 LPIN1 KANSL2 CD6 RBM14 ANKRD11 TRAPPC10 PCNX1 NKTR	3.76e-06	432	140	12	M41149
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	PTBP3 SP4 TUT4 TSPOAP1 AFF3 SHC4 SPOCK2 SORBS1 ZNF318 TNRC6C RFX7 LPIN1 AJAP1 CELF1 ASXL3 TNRC6A NAV3 CAMTA1 SEZ6L	7.05e-06	1106	140	19	M39071
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	PTBP3 SPRY1 AAK1 APBB1 SPOCK2 TNRC6C WNK1 ZAP70 LPIN1 RGS14 JUN EEF1D CD6 CELF1 PCNX1 NKTR ZNF292	7.71e-06	911	140	17	M40038
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	PHACTR2 AFF3 SPOCK2 ZNF318 RFX7 B4GALT1 JUN CD6 ATAD2B RBM14 TRAPPC10 NKTR	9.60e-06	474	140	12	M40991
Coexpression	GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	PTBP3 SPRY1 MAN2A1 PON2 SORBS1 ZNF318 CRYBG3 KDM1B	1.26e-05	200	140	8	M5089
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_483_5P_GENES	BCL9L FOXP4 CELF1	2.38e-05	11	140	3	MM17503
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	CARM1 ZXDC C2orf69 TUT4 AAK1 SPOCK2 LPIN1 RBM14 ANKRD11 TMEM131 NKTR SRRM2 SPEN UVRAG HCFC1 EP300	2.80e-05	905	140	16	M40865
Coexpression	TABULA_MURIS_SENIS_TRACHEA_T_CELL_AGEING	SPRY1 SP2 ABCA2 TUT4 AAK1 WNK1 ORAI1 NABP2 TNRC6A ANKRD11 PUM1	2.84e-05	445	140	11	MM3853
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	TUT4 ZNF318 FOXJ3 PHC2 AJAP1 NAV3 PPIP5K2 PUM1 SPEN	3.53e-05	300	140	9	M8702
Coexpression	BENPORATH_NANOG_TARGETS	BCL9L SPRY1 SP2 UBAP2 SEC24A SPART SORBS1 TSC22D2 MEF2A JUN SALL2 PITX2 TNRC6A RBM14 HLTF NKTR	7.93e-05	988	140	16	M6616
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	BCL9L RBMS2 TSC22D2 KMT2D TNRC6A CRYBG1 SPEN	8.02e-05	192	140	7	M8272
Coexpression	GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	SCAF8 BTBD10 AFF3 AAK1 WNK1 NABP2 TRAPPC10	9.12e-05	196	140	7	M9515
Coexpression	GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN	PTBP3 ZNF318 KANSL1 DCLRE1A TMEM131 NKTR MED13	9.42e-05	197	140	7	M8464
Coexpression	GSE12366_GC_BCELL_VS_PLASMA_CELL_UP	WNK1 PHC2 CELF1 RBM14 PRR14L KDM1B UVRAG	9.42e-05	197	140	7	M3166
Coexpression	GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	SRSF11 LPIN1 KANSL2 CD6 ANKRD11 PRR14L NKTR	9.42e-05	197	140	7	M3193
Coexpression	ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN	ZAN FOXJ3 KMT2D SPEN SAP130	9.42e-05	85	140	5	M41085
Coexpression	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	CARM1 AAK1 APBB1 CHD8 ZNF318 GLI3 ANKRD11	1.00e-04	199	140	7	M7259
Coexpression	GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	AFF3 USP42 TNRC6A TMEM131 PRR14L CRYBG3 SRRM2	1.00e-04	199	140	7	M6987
Coexpression	GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	TUT4 TUT7 TSC22D2 PHC2 KMT2D ATAD2B ZNF292	1.03e-04	200	140	7	M9463
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP	PTBP3 B4GALT1 LPIN1 TIMM8A CEP41 RBM14 TRAPPC10	1.03e-04	200	140	7	M3970
Coexpression	GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP	PON2 RGS14 KANSL2 TNRC6A CRYBG1 TMEM131 HCFC1	1.03e-04	200	140	7	M9080
Coexpression	GSE11924_TFH_VS_TH2_CD4_TCELL_UP	BCL9L SCAF8 CC2D1B PCNX1 PRR14L SRRM2 CNOT3	1.03e-04	200	140	7	M3153
Coexpression	GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	DDX31 MAN2A1 ZNF628 NUP155 DHODH USP40 RACGAP1	1.03e-04	200	140	7	M6997
Coexpression	PROVENZANI_METASTASIS_UP	FOXA2 WNK1 JUN DHODH HLTF TNS3 BORA	1.17e-04	204	140	7	M4100
Coexpression	MENON_FETAL_KIDNEY_4_PODOCYTES	PTBP3 DACH1 PON2 SPOCK2 NFE2L1 ANKRD11 SRRM2	1.24e-04	206	140	7	M39254
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	TSPOAP1 VSTM2B FOXA2 ONECUT1 LPIN1 AJAP1 ASXL3 BHLHE22 MED12L USH2A	2.07e-04	465	140	10	M39066
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP	TUT4 AAK1 EP300	2.13e-04	22	140	3	M40867
Coexpression	FIGUEROA_AML_METHYLATION_CLUSTER_7_DN	ASXL3 TACR3	2.80e-04	5	140	2	M2181
Coexpression	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	TBX18 AJAP1 BHLHE22 TNS3	2.83e-04	59	140	4	MM528
Coexpression	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	TBX18 AJAP1 BHLHE22 TNS3	2.83e-04	59	140	4	M1238
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000	TUT4 SPOCK2 SIX4 RFX7 TIMM8A SALL2 KANSL1 NUP155 CEP41 RBM14 HLTF CEP152 TACR3 CAMTA1 MED13 BORA ZNF292	1.38e-05	779	139	17	gudmap_developingKidney_e15.5_Cap mesenchyme_1000
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TUT4 MAN2A1 WNK1 KANSL1 TNRC6A NKTR PUM1 SRRM2 MED13 ZNF292	5.62e-10	192	140	10	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MAN2A1 AAK1 SRSF11 ZAP70 CD6 KANSL1 RBM14 CRYBG1 PCNX1 NKTR	5.62e-10	192	140	10	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	TUT4 MAN2A1 WNK1 KANSL1 TNRC6A NKTR PUM1 SRRM2 MED13 ZNF292	5.91e-10	193	140	10	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 AAK1 SPOCK2 TNRC6C ZAP70 CD6 TNRC6A CRYBG1 NKTR	1.01e-08	191	140	9	d9a6f61fcda4f5352488f7f55cb9b57aeacc717f
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	C2orf69 MAN2A1 LATS1 TRAPPC10 PCNX1 CRYBG3 KDM1B PUM1 MED13	1.10e-08	193	140	9	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AAK1 SRSF11 ZAP70 LPIN1 KANSL1 ATAD2B ANKRD11 NKTR ZNF292	1.44e-08	199	140	9	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	AAK1 SPOCK2 TNRC6C ZAP70 CD6 TNRC6A CRYBG1 NKTR	1.21e-07	183	140	8	f2ef110bf29b1a8276ef216238363e542db262c1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 AAK1 APBB1 SPOCK2 TNRC6C CD6 TNRC6A NKTR	1.69e-07	191	140	8	696921a4f160b6b55698652488ed781e855e5e51
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tfh\|lymph-node_spleen / Manually curated celltypes from each tissue	MAN2A1 AAK1 SPOCK2 ZAP70 JUN CD6 CRYBG1 PCNX1	2.22e-07	198	140	8	fbdd37ca3d4b61f266bf6146662cb300ef67b850
ToppCell	control-MAIT\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPRY1 ABCA2 PHACTR2 AAK1 SPOCK2 ZAP70 JUN CD6	2.40e-07	200	140	8	aeea4bda2e38cc6db571ed2b47ce022d637619bd
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	MAN2A1 AAK1 SPOCK2 KANSL3 CRYBG1 PCNX1 NKTR	8.28e-07	162	140	7	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT7 TSC22D2 WNK1 MEF2A JUN NAV3 MED12L	1.39e-06	175	140	7	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SPOCK2 VSTM2B ZAP70 AJAP1 MED12L CRYBG1 MYO18B	1.94e-06	184	140	7	3e9d75af578297950e469f23fb2d28393a2feef8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	AAK1 SPOCK2 TNRC6C ZAP70 JUN CD6 RBM14	2.08e-06	186	140	7	c793a3d5709ad504c12fc3b2337746d90236d3ca
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AAK1 SPOCK2 WNK1 ZAP70 CD6 CRYBG1 PCNX1	2.16e-06	187	140	7	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	KANSL1 ANKRD11 PCNX1 TMEM131 NKTR SPEN MED13	2.24e-06	188	140	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCL9L AAK1 SPOCK2 TNRC6C ZAP70 CD6 CRYBG1	2.32e-06	189	140	7	9ab77c6fcb573854da5922412f53d2168bda6b58
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCL9L AAK1 SPOCK2 TNRC6C ZAP70 CD6 CRYBG1	2.32e-06	189	140	7	5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	AAK1 SPOCK2 ZAP70 JUN KANSL1 NKTR SRRM2	2.32e-06	189	140	7	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SEH1L C2orf69 SPART KANSL3 KMT2D KANSL1 RBM14	2.40e-06	190	140	7	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TUT4 AFF3 SPOCK2 TRAPPC10 NKTR CCDC191 UVRAG	2.48e-06	191	140	7	a073d58154c801ec499fd969f42b7f1ee7f15d79
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	AAK1 SRSF11 EEF1D ANKRD11 NKTR SRRM2 ZNF292	2.57e-06	192	140	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SEH1L C2orf69 SPART KANSL3 KMT2D KANSL1 RBM14	2.57e-06	192	140	7	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZNF423 RBMS2 AFF3 DACH1 PON2 SORBS1 NAV3	2.66e-06	193	140	7	ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AAK1 SPOCK2 ZAP70 EEF1D CD6 CRYBG1 PCNX1	2.85e-06	195	140	7	e4caa01d2040a6f4dd90e68c2e1e99c5405e2eba
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 AFF3 SPOCK2 JUN CD6 CRYBG1 ZNF292	2.85e-06	195	140	7	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	BCL9L ABCA2 SPOCK2 ZAP70 CD6 NKTR SRRM2	3.05e-06	197	140	7	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ABCA2 AAK1 TNRC6C ZAP70 LPIN1 NKTR ZNF292	3.05e-06	197	140	7	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	normal_Lymph_Node-T/NK_cells-Naive_CD4+_T\|normal_Lymph_Node / Location, Cell class and cell subclass	AAK1 APBB1 SPOCK2 ZAP70 JUN EEF1D CD6	3.05e-06	197	140	7	a25954c534da16d5ce57cfe3a3a01beb2f556a5c
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	TUT7 SRSF11 EEF1D CEP152 NKTR SRRM2 ZNF292	3.05e-06	197	140	7	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AAK1 APBB1 SPOCK2 ZAP70 EEF1D CD6 PCNX1	3.05e-06	197	140	7	076fc05b32200e0a8a1e35d03c295111468d92a9
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	DACH1 WNK1 KANSL1 USP42 GLI3 TMEM131 HCFC1	3.26e-06	199	140	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	ACACB CC2D1B RFX7 B4GALT1 LPIN1 GSG1L BORA	3.37e-06	200	140	7	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SRSF11 KANSL1 ATAD2B ANKRD11 NKTR SRRM2 ZNF292	3.37e-06	200	140	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Control-Control-Lymphocyte-T/NK-gd_T\|Control / Disease, condition lineage and cell class	BCL9L ABCA2 AAK1 SPOCK2 ZAP70 CD6 KANSL1	3.37e-06	200	140	7	88e502c141bbb73e62aa5830d24bd645376e5f3a
ToppCell	Control-Control-Lymphocyte-T/NK-MAIT\|Control / Disease, condition lineage and cell class	SPRY1 PHACTR2 AAK1 SPOCK2 TNRC6C JUN CD6	3.37e-06	200	140	7	888a8045e0457cd9d0c570360cca20a6efb44f13
ToppCell	Mild/Remission-B_naive-1\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TUT4 TUT7 SPART ZNF318 PCNX1 CCDC191	6.13e-06	143	140	6	bd3f5fbd4e9e4dc414682db5607494f3ce988deb
ToppCell	3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-MAIT\|Lung / Manually curated celltypes from each tissue	SPRY1 AFF3 SPOCK2 RGS14 JUN CD6	9.73e-06	155	140	6	72c61be0a8d3ee10600a33c58fb01c35fd3f14d4
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TUT4 TUT7 SPART ZNF318 PCNX1 CCDC191	9.73e-06	155	140	6	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	CV-Healthy-3\|CV / Virus stimulation, Condition and Cluster	SPRY1 RBMS2 SPART SYNGAP1 PCNX1 CRYBG3	1.21e-05	161	140	6	fd4a79385ea967b9900dc76a3add813b894a3a28
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	ZXDC FOXJ3 SYNGAP1 USP40 PUM1 CCDC191	1.44e-05	166	140	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	TUT4 AAK1 KANSL1 CRYBG1 PCNX1 NKTR	1.70e-05	171	140	6	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB ZNF423 PON2 JUN GLI3 TNS3	2.34e-05	181	140	6	0c3f469bed108994ed696230e3c30343f7a301d3
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 MEF2A JUN ANKRD11 UVRAG EP300	2.57e-05	184	140	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPRY1 LPIN1 JUN CRYBG1 PCNX1 NKTR	2.57e-05	184	140	6	cef3ee2a4a0af961aa3b4c92150d423e841ae8c1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AAK1 SPOCK2 TNRC6C CD6 TNRC6A NKTR	2.57e-05	184	140	6	5350b58aa9979631228835d11eb45ddf81d08bff
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	AFF3 PON2 SPOCK2 SORBS1 MEF2A PHLDB1	2.90e-05	188	140	6	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	NS-critical-d_0-4-Lymphoid-CTL\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AAK1 SPOCK2 TNRC6C ZAP70 CD6 NKTR	2.99e-05	189	140	6	fb7572fb4c7c43886d57a025decad076f32a14c4
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPRY1 JUN ANKRD11 CRYBG1 PCNX1 NKTR	2.99e-05	189	140	6	2c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 SPOCK2 ZAP70 CD6 USP42 ZNF292	3.08e-05	190	140	6	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB ZNF423 PON2 STOX1 GLI3 TNS3	3.08e-05	190	140	6	5c64b727669b23d2a23c8ad1d5d6caab7af37d56
ToppCell	T_cells-Effector_memory_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	AAK1 APBB1 SPOCK2 JUN CD6 PCNX1	3.08e-05	190	140	6	13dc3a0aaa554f63eabac37726bd1f11b66fb3dd
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	AAK1 SPOCK2 ZAP70 CD6 CRYBG1 PCNX1	3.08e-05	190	140	6	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 SRSF11 CRYBG1 NKTR SRRM2 ZNF292	3.17e-05	191	140	6	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPRY1 AAK1 SPOCK2 TNRC6C CRYBG1 PCNX1	3.17e-05	191	140	6	142f98cabf8737b28369315b3d7a0797ded88e03
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th17\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPRY1 AAK1 SPOCK2 RGS14 CD6 CRYBG1	3.17e-05	191	140	6	b3ed4797a7a9810cf3507e0d0f23f45c35bd8ba2
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEF2A B4GALT1 JUN NAV3 MED12L SRRM2	3.36e-05	193	140	6	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AAK1 SRSF11 ZAP70 ATAD2B NKTR ZNF292	3.36e-05	193	140	6	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tfh\|lymph-node_spleen / Manually curated celltypes from each tissue	AAK1 SPOCK2 TNRC6C JUN CD6 CRYBG1	3.36e-05	193	140	6	dea7d0b2eadff01e0e169c6916dea04253521d48
ToppCell	ILEUM-inflamed-(1)_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPRY1 AAK1 SPOCK2 JUN CD6 CRYBG1	3.46e-05	194	140	6	cf22bd6afe51c42cb151c37a8b65c98649dae1a4
ToppCell	(1)_T_cells\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	AAK1 SPOCK2 ZAP70 RGS14 JUN CD6	3.46e-05	194	140	6	f9639f57976bbfff1d6140a542cd50a8b1ded2dc
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF423 AFF3 DACH1 PON2 SORBS1 PHLDB1	3.46e-05	194	140	6	40842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Tfh\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PHACTR2 AAK1 SPOCK2 ZAP70 EEF1D CD6	3.56e-05	195	140	6	ea83c3c93ec4e09029185508bdbd6d9cc5e441d5
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-Activated_CD8_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPOCK2 ZAP70 RGS14 JUN EEF1D CD6	3.56e-05	195	140	6	a7c70284ac47dcc6f47ee2805b76b14edfa1c0b9
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	BCL9L ABCA2 AAK1 SPOCK2 ZAP70 CD6	3.66e-05	196	140	6	aec2b11a6048048820271266fdc8b8d806da9993
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AAK1 SPOCK2 ZAP70 CD6 CRYBG1 PCNX1	3.66e-05	196	140	6	e4c76e7ad68455e51fe93ce588bcec9383f8654b
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BCL9L ABCA2 AAK1 SPOCK2 ZAP70 CD6	3.66e-05	196	140	6	aa0dc04f94a575cd442ee473b75a4f54268e4105
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPRY1 WNK1 PITX1 PITX2 ANKRD11 SRRM2	3.66e-05	196	140	6	a85f5f1e6acc798e9e02b1a21e0ffe87a323c333
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BCL9L ABCA2 AAK1 SPOCK2 ZAP70 CD6	3.66e-05	196	140	6	502834a16d5ada93af7ab9af0c3dc652086964bd
ToppCell	Control-B_naive-8\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TUT4 AFF3 AAK1 PON2 ANKRD11 CCDC191	3.66e-05	196	140	6	54074da84000e4749ade8acc542f05a275bf829f
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AFF3 DACH1 PON2 SORBS1 MEF2A AJAP1	3.66e-05	196	140	6	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 SPOCK2 TNRC6C ZAP70 CD6 NKTR	3.66e-05	196	140	6	a9157809122e6fc5783a291522f103bef30943e4
ToppCell	critical-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PHACTR2 AAK1 SPOCK2 ZAP70 RGS14 CD6	3.66e-05	196	140	6	861665912eb0538b083d3eee77190925b3a43c24
ToppCell	tumor_Lung-T/NK_cells-Naive_CD4+_T\|tumor_Lung / Location, Cell class and cell subclass	AAK1 SPOCK2 ZAP70 JUN EEF1D CD6	3.66e-05	196	140	6	d5bab34992bf3ac08f20c07358f9745eff5b50d8
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BCL9L ABCA2 AAK1 SPOCK2 ZAP70 CD6	3.66e-05	196	140	6	ae9bf04531b9bda819608d90736c4405a6c3df41
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZNF423 RBMS2 AFF3 DACH1 SORBS1 PHLDB1	3.66e-05	196	140	6	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHC4 SORBS1 ONECUT1 LPIN1 AJAP1 NAV3	3.66e-05	196	140	6	a58bdf9de05d13d84211e09a933679d485bf8ab4
ToppCell	NS-critical-d_16-33-Lymphoid-Treg\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AAK1 SPOCK2 TNRC6C ZAP70 RGS14 CD6	3.66e-05	196	140	6	ad2d17cbfa1af4142f9cec2ea1a37d11d4b4151a
ToppCell	moderate-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PHACTR2 AAK1 SPOCK2 ZAP70 CD6 NKTR	3.66e-05	196	140	6	9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCell	Control-Lymphoid_T/NK-gd_T\|Control / Disease group, lineage and cell class	BCL9L ABCA2 AAK1 SPOCK2 ZAP70 CD6	3.66e-05	196	140	6	98b11aada6bc5d928ef618573dc912d4d74a1092
ToppCell	(1)_T_CD8_MAIT\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PHACTR2 AAK1 SPOCK2 ZAP70 JUN CD6	3.66e-05	196	140	6	5fc99a8e3dde12fd0b0b2e0a2db48ac16b42739e
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RBMS2 AFF3 DACH1 PON2 SORBS1 MEF2A	3.66e-05	196	140	6	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AAK1 SPOCK2 ZAP70 CD6 CRYBG1 PCNX1	3.76e-05	197	140	6	b044833de12f2b9eb702155563cd8932bc16e0ef
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AAK1 SRSF11 ZAP70 ANKRD11 NKTR ZNF292	3.76e-05	197	140	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	ZNF423 AFF3 DACH1 PON2 SORBS1 MEF2A	3.76e-05	197	140	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-Activated_CD4_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPOCK2 ZAP70 JUN EEF1D CD6 CRYBG1	3.76e-05	197	140	6	2f2e5a5e1cb00b9e51c1a9f86d34ac65cb8b3999
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	TUT4 KANSL1 ANKRD11 NKTR SRRM2 ZNF292	3.76e-05	197	140	6	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCL9L AAK1 SPOCK2 TNRC6C ZAP70 CD6	3.76e-05	197	140	6	59b1fb93a39dcf8c994d2b7dc2906dae74c57527
ToppCell	severe_COVID-19-CD4+_CTL\|severe_COVID-19 / disease group, cell group and cell class (v2)	BCL9L AAK1 SPOCK2 ZAP70 JUN CD6	3.76e-05	197	140	6	e51b7cd03b1450dc8601b4be0453b104d6a5f955
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	AAK1 SPOCK2 TNRC6C EEF1D CD6 CRYBG1	3.87e-05	198	140	6	0b9d3518d60d877e1423517fab374381bf678a2b
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AAK1 APBB1 SPOCK2 ZAP70 CD6 PCNX1	3.87e-05	198	140	6	c4d8d133e571ad3a7c5de93aa7befb67cb7a003d
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	TUT4 KANSL1 ANKRD11 NKTR SRRM2 ZNF292	3.87e-05	198	140	6	44417089b62056269cac38d3134ff209c05b7007
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SPRY1 PHACTR2 PON2 PITX2 TACR3 GSG1L	3.87e-05	198	140	6	55e583321f60c95898d93cd0d2615c6692db52ec
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AAK1 SPOCK2 ZAP70 ORAI1 EEF1D CD6	3.87e-05	198	140	6	f77f21f21566a04145217ebf85cd14db48945056
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AAK1 APBB1 SPOCK2 ZAP70 CD6 PCNX1	3.87e-05	198	140	6	db107a5511571384f26e26c6301aef9a9f2423c4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AAK1 SPOCK2 ZAP70 ORAI1 EEF1D CD6	3.87e-05	198	140	6	7f61a9a3d61992c023cc4bc4571a0a7a1a160833
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AAK1 SPOCK2 ZAP70 ORAI1 EEF1D CD6	3.87e-05	198	140	6	d3d117dc3c2a533365bd2d1a6ab0c60e976d2c10
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AAK1 SPOCK2 ZAP70 ORAI1 EEF1D CD6	3.87e-05	198	140	6	ed39ac9d4b1f50e9086ace3ad3325db0d5f4c323
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUT4 KANSL1 ANKRD11 NKTR SRRM2 ZNF292	3.87e-05	198	140	6	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	control-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPRY1 ABCA2 PHACTR2 SPOCK2 ZAP70 JUN	3.87e-05	198	140	6	13955a4026c97e11d94973ac87bf018f64a2616c
Computational	Genes upregulated in subsets of cells of a given type within various tumors	TUT4 B4GALT1 ANKRD11 NKTR ZNF292	4.40e-05	50	85	5	GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	PTBP3 PCGF2 SPOCK2 SRSF11 RFX7 WNK1 PCNX1 PRR14L NKTR SPEN	2.90e-07	190	140	10	4322_DN
Drug	Azathymine, 6 [932-53-6]; Up 200; 31.4uM; PC3; HT_HG-U133A	AFF3 AAK1 TSC22D2 WNK1 B4GALT1 PHLDB1 ZNF408 DHODH PITX2 PCNX1	4.44e-07	199	140	10	3987_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ZXDC TUT7 PON2 ZNF318 TSC22D2 JUN NABP2 PITX1 RBM14	2.66e-06	189	140	9	1006_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	DDX31 RFX7 WNK1 MEF2A NABP2 DHODH NKTR SRRM2 SPEN	2.66e-06	189	140	9	1045_DN
Drug	Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TUT4 PCGF2 TSC22D2 RFX7 WNK1 JUN CD6 PRR14L LTBP2	2.78e-06	190	140	9	4115_DN
Drug	radicicol; Up 200; 0.1uM; HL60; HG-U133A	PHACTR2 ACACB SEC24A SPOCK2 MAST2 CELF1 GLI3 ATAD2B ANKRD11	3.16e-06	193	140	9	544_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	DDX31 SRSF11 WNK1 JUN PCNX1 CEP152 PRR14L NKTR SPEN	3.30e-06	194	140	9	4312_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	PTBP3 TSPOAP1 ZNF423 AAK1 SPOCK2 ZC2HC1C WNK1 JUN PCNX1	3.30e-06	194	140	9	2223_UP
Drug	Niacin [59-67-6]; Down 200; 32.4uM; HL60; HT_HG-U133A	PTBP3 PCGF2 DDX31 TSC22D2 B4GALT1 CD6 DHODH TRAPPC10 CEP152	3.74e-06	197	140	9	3043_DN
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; PC3; HT_HG-U133A	PTBP3 ZNF423 ZC2HC1C WNK1 MEF2A LPIN1 PHLDB1 DHODH HCFC1	3.89e-06	198	140	9	4007_UP
Drug	Avermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A	RFX7 JUN SALL2 GLI3 TRAPPC10 CEP152 NKTR HCFC1 EP300	3.89e-06	198	140	9	7218_DN
Drug	Phenindione [83-12-5]; Down 200; 18uM; PC3; HT_HG-U133A	ZXDC PCGF2 ACACB SRSF11 ZNF318 JUN SALL2 PITX1 CEP152	4.06e-06	199	140	9	7289_DN
Drug	Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; PC3; HT_HG-U133A	TSPOAP1 ZC2HC1C WNK1 B4GALT1 JUN LATS1 ZNF408 NKTR CNOT3	4.06e-06	199	140	9	5068_DN
Drug	WY-14643; Up 200; 100uM; PC3; HG-U133A	ACACB APBB1 SPART ZNF318 ADAMTS5 MAST2 LPIN1 RGS14 EP300	4.23e-06	200	140	9	481_UP
Drug	Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	SPRY1 SPART SPOCK2 ZAP70 LPIN1 JUN CEP41 PCNX1	2.37e-05	190	140	8	6825_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A	ABCA2 PCGF2 WNK1 B4GALT1 KANSL3 LATS1 HCFC1 CNOT3	2.65e-05	193	140	8	4240_DN
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	DACH1 SRSF11 ZNF318 MAST2 WNK1 ATAD2B TRAPPC10 HCFC1	2.75e-05	194	140	8	1670_DN
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	ZXDC SPART RFX7 MEF2A JUN PITX2 PCNX1 CEP152	2.75e-05	194	140	8	5544_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	PTBP3 DDX31 ZNF318 MEF2A JUN SALL2 TRAPPC10 HCFC1	2.75e-05	194	140	8	7406_DN
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	PTBP3 SRSF11 RFX7 WNK1 JUN PRR14L PPIP5K2 SPEN	2.75e-05	194	140	8	4308_DN
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; HL60; HG-U133A	PHACTR2 SPOCK2 MAST2 B4GALT1 ZNF408 PCNX1 CEP152 SEZ6L	2.96e-05	196	140	8	1738_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	PTBP3 SRSF11 ZNF318 WNK1 SALL2 ATAD2B SRRM2 HCFC1	2.96e-05	196	140	8	1662_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	ZXDC ABCA2 WNK1 FOXJ3 JUN GLI3 HCFC1 EP300	3.07e-05	197	140	8	1635_DN
Drug	Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ABCA2 PCGF2 AAK1 ZNF318 MAST2 NABP2 NKTR HCFC1	3.07e-05	197	140	8	7231_DN
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A	SPRY1 PCGF2 DDX31 AAK1 CHD8 TSC22D2 PRR14L SRRM2	3.18e-05	198	140	8	1997_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SP2 DDX31 SRSF11 MAST2 MEF2A CELF1 PCNX1 SPEN	3.18e-05	198	140	8	1070_DN
Drug	Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A	PTBP3 ABCA2 SPOCK2 B4GALT1 LPIN1 KCNK10 PRR14L NKTR	3.18e-05	198	140	8	5347_UP
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A	DDX31 SEC24A AAK1 DACH1 MAST2 MEF2A JUN PCNX1	3.18e-05	198	140	8	1868_DN
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A	ZXDC PCGF2 ZNF318 RFX7 PHLDB1 CEP152 LTBP2 HCFC1	3.18e-05	198	140	8	7474_DN
Drug	Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A	PHACTR2 DDX31 RBMS2 RGS14 NABP2 PCNX1 SRRM2 HCFC1	3.30e-05	199	140	8	3264_UP
Drug	NSC-350602	SP2 TSPOAP1 DACH1	6.22e-05	13	140	3	CID006917838
Drug	rosiglitazone; Up 200; 10uM; PC3; HT_HG-U133A	DDX31 SORBS1 FOXJ3 LPIN1 RGS14 JUN SEZ6L	8.29e-05	168	140	7	1233_UP
Drug	geldanamycin	ZXDC PTBP3 SP4 PHACTR2 AFF3 RFX7 PRR14L NKTR SRRM2 MED13	1.03e-04	371	140	10	ctd:C001277
Drug	AC1L8131	LATS1 BHLHE22 TNRC6A	1.20e-04	16	140	3	CID000370472
Drug	lomustine; Down 200; 100uM; PC3; HT_HG-U133A	SPRY1 PCGF2 ACACB TSC22D2 FOXA2 GLI3 TNS3	1.27e-04	180	140	7	7094_DN
Drug	Ellipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A	ZXDC SPRY1 DDX31 SCAF8 FOXA2 KANSL2 PUM1	1.27e-04	180	140	7	5779_DN
Drug	Cantharidin [56-25-7]; Up 200; 20.4uM; HL60; HT_HG-U133A	ABCA2 ACACB TSPOAP1 SPOCK2 MAST2 JUN NKTR	1.37e-04	182	140	7	3075_UP
Drug	Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A	SPRY1 SCAF8 FOXA2 JUN KANSL2 GLI3 PUM1	1.46e-04	184	140	7	4610_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	SEC24A SRSF11 CHD8 ZNF318 DHODH HCFC1 MED13	1.61e-04	187	140	7	4989_DN
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; HL60; HG-U133A	PTBP3 PCGF2 DACH1 MAST2 DHODH CEP152 ZNF292	1.72e-04	189	140	7	1742_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	SRSF11 WNK1 JUN PCNX1 PRR14L NKTR SPEN	1.72e-04	189	140	7	4304_DN
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	ACACB SPOCK2 SORBS1 LPIN1 CD6 NKTR LTBP2	1.72e-04	189	140	7	5586_UP
Drug	Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A	PHACTR2 AAK1 SPART ADAMTS5 MAST2 LPIN1 RGS14	1.72e-04	189	140	7	1700_UP
Drug	Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; PC3; HT_HG-U133A	SPRY1 PHACTR2 ACACB SEC24A JUN CELF1 SRRM2	1.72e-04	189	140	7	1807_UP
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	PTBP3 SRSF11 WNK1 PCNX1 PRR14L NKTR SPEN	1.78e-04	190	140	7	4306_DN
Drug	colchicine; Up 200; 1uM; SKMEL5; HG-U133A	SEC24A AAK1 SPART TSC22D2 B4GALT1 JUN SPEN	1.78e-04	190	140	7	630_UP
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PTBP3 ABCA2 PCGF2 MEF2A JUN PHLDB1 CNOT3	1.84e-04	191	140	7	7438_DN
Drug	Astemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A	SPRY1 ACACB APBB1 FOXA2 DCLRE1A PRR14L LTBP2	1.84e-04	191	140	7	4471_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A	GATAD2A SRSF11 B4GALT1 JUN GLI3 PCNX1 SRRM2	1.84e-04	191	140	7	7435_DN
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A	ACACB RFX7 ZNF408 ATAD2B DHODH NKTR SRRM2	1.90e-04	192	140	7	1792_UP
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	PTBP3 RFX7 MAST2 JUN GLI3 PCNX1 PRR14L	1.90e-04	192	140	7	4110_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A	TSPOAP1 TSC22D2 LPIN1 JUN ZNF408 SRRM2 CNOT3	1.90e-04	192	140	7	2919_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	PHACTR2 RFX7 WNK1 JUN PITX1 PRR14L SPEN	1.90e-04	192	140	7	4104_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	MEF2A RGS14 CELF1 TRAPPC10 PRR14L SRRM2 ZNF292	1.90e-04	192	140	7	7280_DN
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; HL60; HT_HG-U133A	ABCA2 CELF1 PITX2 KCNK10 TRAPPC10 PCNX1 LTBP2	1.96e-04	193	140	7	2346_UP
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A	ABCA2 PCGF2 WNK1 GLI3 ZNF408 PITX1 CEP152	1.96e-04	193	140	7	5628_DN
Drug	STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A	ZXDC SPRY1 RFX7 FOXA2 WNK1 PITX1 DCLRE1A	1.96e-04	193	140	7	6427_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	SEC24A SRSF11 ZNF408 DHODH SRRM2 HCFC1 CNOT3	1.96e-04	193	140	7	6981_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	PTBP3 DDX31 MAST2 JUN ZNF408 ATAD2B EP300	1.96e-04	193	140	7	6967_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	PCGF2 DACH1 ZNF318 PHLDB1 TRAPPC10 SRRM2 HCFC1	1.96e-04	193	140	7	1667_DN
Drug	Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A	TUT4 AAK1 SORBS1 TSC22D2 LPIN1 AJAP1 HCFC1	1.96e-04	193	140	7	3534_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A	PTBP3 ACACB ZNF318 MEF2A PCNX1 NKTR BORA	1.96e-04	193	140	7	7388_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	ABCA2 DACH1 MAST2 PHLDB1 SALL2 AJAP1 HCFC1	2.02e-04	194	140	7	4411_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	ZNF423 DACH1 TSC22D2 WNK1 JUN PCNX1 CNOT3	2.02e-04	194	140	7	3377_DN
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	ZXDC PTBP3 PCGF2 MEF2A JUN RBM14 HCFC1	2.02e-04	194	140	7	1226_DN
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	SPRY1 ABCA2 PCGF2 ONECUT1 B4GALT1 CEP41 CNOT3	2.09e-04	195	140	7	2813_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	CHD8 SORBS1 TSC22D2 LPIN1 DHODH PCNX1 HCFC1	2.09e-04	195	140	7	4644_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	ZNF423 AAK1 SPOCK2 TSC22D2 CD6 PITX2 NKTR	2.09e-04	195	140	7	5576_UP
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A	ZXDC PTBP3 SEC24A WNK1 LPIN1 PITX1 TRAPPC10	2.09e-04	195	140	7	6643_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	DDX31 WNK1 FOXJ3 PHLDB1 NFE2L1 ZNF408 PITX1	2.09e-04	195	140	7	1665_DN
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A	PHACTR2 PCGF2 TSPOAP1 AFF3 DACH1 WNK1 PITX2	2.09e-04	195	140	7	6200_DN
Drug	DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A	SPRY1 TUT4 ZNF423 SPOCK2 LPIN1 RGS14 CEP41	2.15e-04	196	140	7	2877_UP
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A	PTBP3 ABCA2 TUT4 WNK1 RGS14 PHLDB1 CD6	2.15e-04	196	140	7	4000_UP
Drug	Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A	PTBP3 PCGF2 CHD8 MAST2 CELF1 CEP152 NKTR	2.15e-04	196	140	7	5293_DN
Drug	Bisoprolol fumarate; Down 200; 9uM; PC3; HT_HG-U133A	SORBS1 TSC22D2 MAST2 B4GALT1 PHLDB1 NABP2 NKTR	2.15e-04	196	140	7	6748_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A	TUT4 AAK1 MAST2 WNK1 PHLDB1 PITX1 DCLRE1A	2.15e-04	196	140	7	203_DN
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	PTBP3 AAK1 DACH1 B4GALT1 JUN CEP41 LTBP2	2.15e-04	196	140	7	2198_DN
Drug	Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	PTBP3 TSC22D2 ONECUT1 B4GALT1 RGS14 LATS1 PCNX1	2.15e-04	196	140	7	4806_UP
Drug	Gabazine [105538-73-6]; Down 200; 10.8uM; PC3; HT_HG-U133A	PCGF2 WNK1 B4GALT1 KANSL3 RGS14 CD6 CNOT3	2.15e-04	196	140	7	4236_DN
Drug	Asiaticoside [16830-15-2]; Up 200; 4.2uM; HL60; HT_HG-U133A	ABCA2 DDX31 ADAMTS5 PHC2 RGS14 CEP41 PCNX1	2.15e-04	196	140	7	2943_UP
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; PC3; HT_HG-U133A	PTBP3 APBB1 B4GALT1 PHLDB1 PCNX1 CEP152 HCFC1	2.15e-04	196	140	7	3760_DN
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	TUT4 ACACB MAST2 PHLDB1 PITX1 PCNX1 PRR14L	2.15e-04	196	140	7	2888_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	AAK1 ZNF318 TSC22D2 LPIN1 JUN PITX1 PCNX1	2.15e-04	196	140	7	2312_DN
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A	SPRY1 RBMS2 AAK1 ZNF318 MAST2 B4GALT1 CD6	2.15e-04	196	140	7	3259_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A	GATAD2A JUN ZNF408 NABP2 TRAPPC10 HCFC1 EP300	2.15e-04	196	140	7	1156_DN
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A	PCGF2 AAK1 SPOCK2 LATS1 SALL2 ZNF408 PITX2	2.22e-04	197	140	7	3127_DN
Drug	Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	DDX31 SPART SRSF11 GLI3 ZNF408 TRAPPC10 ZNF292	2.22e-04	197	140	7	5340_DN
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A	PTBP3 ABCA2 RBMS2 APBB1 TSC22D2 WNK1 PCNX1	2.22e-04	197	140	7	4474_DN
Drug	Stachydrine hydrochloride; Up 200; 22.2uM; MCF7; HT_HG-U133A	SEC24A SORBS1 TSC22D2 B4GALT1 PHLDB1 CD6 SEZ6L	2.22e-04	197	140	7	6805_UP
Drug	Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ZNF423 SORBS1 CD6 AJAP1 CEP41 PCNX1 LTBP2	2.22e-04	197	140	7	2238_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	PTBP3 PCGF2 DACH1 WNK1 MEF2A JUN KANSL2	2.22e-04	197	140	7	1634_DN
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A	SPRY1 ABCA2 SPOCK2 ZNF318 MAST2 PHLDB1 LTBP2	2.22e-04	197	140	7	3255_UP
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; MCF7; HT_HG-U133A	PCGF2 DACH1 SPOCK2 PHLDB1 CD6 PITX1 HCFC1	2.22e-04	197	140	7	6237_UP
Drug	dexamethasone; Down 200; 1uM; MCF7; HG-U133A	ZXDC SPART B4GALT1 JUN PHLDB1 ZNF408 SEZ6L	2.22e-04	197	140	7	255_DN
Drug	Hydroflumethiazide [135-09-1]; Down 200; 12uM; PC3; HT_HG-U133A	DDX31 APBB1 ZNF318 FOXA2 RGS14 SALL2 DCLRE1A	2.22e-04	197	140	7	1809_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZXDC PHACTR2 PCGF2 WNK1 JUN GLI3 HCFC1	2.22e-04	197	140	7	1641_DN
Drug	Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A	PCGF2 DACH1 WNK1 FOXJ3 ZNF408 PITX1 PITX2	2.22e-04	197	140	7	5685_DN
Drug	Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A	ABCA2 TUT4 DACH1 LPIN1 PHLDB1 PITX2 KCNK10	2.22e-04	197	140	7	4077_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A	APBB1 SRSF11 SORBS1 WNK1 JUN LATS1 NKTR	2.29e-04	198	140	7	4301_UP
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; PC3; HT_HG-U133A	SP2 AFF3 RGS14 PHLDB1 CD6 PITX1 DHODH	2.29e-04	198	140	7	6635_UP
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 SRRM2 MED13 ZNF292	9.52e-07	17	135	4	DOID:0060307 (is_implicated_in)
Disease	congenital heart disease (implicated_via_orthology)	CHD8 KMT2D USP42 SAP130 HCFC1	1.65e-05	69	135	5	DOID:1682 (implicated_via_orthology)
Disease	Clumsiness - motor delay	MED12L MED13	2.08e-05	2	135	2	C0520947
Disease	T-Cell Lymphoma	KMT2D ASXL3 EP300	5.02e-05	16	135	3	C0079772
Disease	Motor delay	MED12L MED13	6.21e-05	3	135	2	C1854301
Disease	waist-hip ratio	C2orf69 ZNF423 AFF3 ZNF318 TSC22D2 RFX7 WNK1 ONECUT1 MEF2A TBX18 CELF1 GLI3 TNRC6A NAV3 PCNX1 LTBP2	1.59e-04	1226	135	16	EFO_0004343
Disease	Delayed speech and language development	MED12L MED13	2.06e-04	5	135	2	C0454644
Disease	pulse pressure measurement	GATAD2A ZNF423 ZC2HC1C ZNF318 TSC22D2 MAST2 PHC2 TBX18 KANSL1 CELF1 ATAD2B TNRC6A ANKRD11 DCLRE1A LTBP2 HCFC1 TNS3	2.15e-04	1392	135	17	EFO_0005763
Disease	Intellectual Disability	PCGF2 AFF3 CHD8 SYNGAP1 KANSL1 MED12L PUM1 MED13 ZNF292	2.25e-04	447	135	9	C3714756
Disease	cortical surface area measurement	SPRY1 SP4 ZAN ZNF423 TUT7 TSC22D2 STOX1 MAST2 SLC26A1 PHC2 KANSL1 GLI3 ATAD2B TNRC6A KCNK10 NAV3	4.44e-04	1345	135	16	EFO_0010736
Disease	colorectal cancer	PTBP3 BCL9L UBAP2 SPOCK2 WNK1 ZAP70 PCNX1 DCLRE1A PUM1 TNS3	4.79e-04	604	135	10	MONDO_0005575
Disease	Abnormality of the skeletal system	PCGF2 ZNF292	5.71e-04	8	135	2	C4021790
Disease	Autism Spectrum Disorders	CHD8 CEP41 ANKRD11 USH2A	6.37e-04	85	135	4	C1510586
Disease	Abnormality of the face	PUM1 ZNF292	7.32e-04	9	135	2	C4025871
Disease	red blood cell density measurement	SP4 AFF3 SORBS1 RFX7 MAST2 WNK1 PHC2 B4GALT1 RGS14 KANSL1 CAMTA1 TNS3	7.44e-04	880	135	12	EFO_0007978
Disease	Neurodevelopmental Disorders	SYNGAP1 ASXL3 ANKRD11 ZNF292	8.93e-04	93	135	4	C1535926
Disease	QRS-T angle	KANSL1 PITX2 PCNX1 MYO18B	1.45e-03	106	135	4	EFO_0020097
Disease	alcohol consumption measurement	C2orf69 DDX31 ACACB AFF3 PHC2 B4GALT1 KANSL1 CELF1 GLI3 DHODH TNRC6A ANKRD11 CAMTA1 EP300	1.70e-03	1242	135	14	EFO_0007878
Disease	macula measurement	TSC22D2 SYNGAP1 KANSL1 ATAD2B TNRC6A	1.81e-03	189	135	5	EFO_0008375
Disease	dystonia (is_implicated_in)	TSPOAP1 TIMM8A	1.82e-03	14	135	2	DOID:543 (is_implicated_in)
Disease	cortical thickness	GATAD2A ZNF423 ZNF318 TSC22D2 STOX1 MAST2 PHLDB1 KANSL1 GLI3 TNRC6A NAV3 TMEM131 CAMTA1	1.83e-03	1113	135	13	EFO_0004840
Disease	Diffuse Large B-Cell Lymphoma	KMT2D SPEN EP300	2.07e-03	55	135	3	C0079744
Disease	pain	SP4 AFF3 SPOCK2 LATS1 ATAD2B	2.12e-03	196	135	5	EFO_0003843
Disease	Cardiovascular Abnormalities	PCGF2 ZNF292	2.39e-03	16	135	2	C0243050
Disease	calcium measurement	BTBD10 AAK1 CHD8 ZNF318 RGS14 EEF1D USP40 TMEM131 MYO18B	2.47e-03	628	135	9	EFO_0004838
Disease	smoking status measurement	MAN2A1 GATAD2A ZNF423 AFF3 DACH1 MAST2 PHC2 SYNGAP1 KANSL1 TNRC6A MED12L CAMTA1 USH2A	2.61e-03	1160	135	13	EFO_0006527
Disease	mood instability measurement	KANSL1 CELF1 TNRC6A EP300	2.89e-03	128	135	4	EFO_0008475
Disease	Disorder of eye	ZNF423 TIMM8A PITX2 CEP41 USH2A	2.98e-03	212	135	5	C0015397
Disease	reticulocyte measurement	UBAP2 GATAD2A TUT7 AFF3 TSC22D2 FOXP4 KANSL1 CELF1 USP42 ATAD2B TMEM131 TNS3	3.33e-03	1053	135	12	EFO_0010700
Disease	eosinophil count	STOX1 WNK1 ZAP70 PHC2 KANSL3 RGS14 KANSL1 COG6 MED12L ANKRD11 PCNX1 TMEM131 LTBP2 UVRAG ZNF292	3.40e-03	1488	135	15	EFO_0004842
Disease	hearing loss	ZNF318 MAST2 PHLDB1	3.62e-03	67	135	3	EFO_0004238
Disease	renal system measurement	SCAF8 RGS14	3.74e-03	20	135	2	EFO_0004742
Disease	Anophthalmia-microphthalmia syndrome	DACH1 PITX2	4.12e-03	21	135	2	cv:C5680330
Disease	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	NUP155 PITX2	4.52e-03	22	135	2	C1843687

Protein segments in the cluster

Peptide	Gene	Start	Entry
GSQGSLSNASALSPS	AFF3	1131	P51826
SQAQQSSPGLGLINS	EP300	106	Q09472
SSLGVGQQSAPNLST	EP300	441	Q09472
TVPNGNNPTGNSLTS	AADAT	196	Q8N5Z0
QKASPNGSISSAGNS	BTBD10	116	Q9BSF8
VSTPLQGGSNSAAAI	B4GALT1	56	P15291
ALETPSAAGSQGNTA	AKAP2	396	Q9Y2D5
VLQPQAGSSQGASSG	CHD8	401	Q9HCK8
SAQNNGSPAQEITGS	CEP152	201	O94986
PQQGSLQLSSSEGGA	CAMTA1	826	Q9Y6Y1
QALASSLIGGTSENP	ANKRD11	1956	Q6UB99
LPQLGIGNASSCSQA	C2orf69	16	Q8N8R5
AVAGPAASVNSSGQQ	CRYBG3	1156	Q68DQ2
QAAGSSNQPGLLASV	AAK1	401	Q2M2I8
ALAAAASAAQNTPSG	CELF1	266	Q92879
ASAAQNTPSGTNALT	CELF1	271	Q92879
SQLLDQSALSPAGGS	ADAMTS5	236	Q9UNA0
NQGQAISAASLPSSA	BHLHE22	311	Q8NFJ8
NCPNSGANATANGTA	GSG1L	51	Q6UXU4
NQSAENGSSLPSAAS	SPATA5	11	Q8NB90
SSSSAVAGGAPEQQA	AJAP1	136	Q9UKB5
INNAGAGDSSRSTLQ	CEP41	126	Q9BYV8
SLSQSAINANSHGGP	APBB1	6	O00213
GSNCNPNLAAASNGS	DACH1	101	Q9UI36
NIQKSLAGSSGPGAS	EEF1D	56	P29692
KLTTGPNNAGAQSSS	ASXL3	371	Q9C0F0
SPAEVALSSSGGNNA	CNOT3	436	O75175
ALSSSGGNNASSQAL	CNOT3	441	O75175
SQPNSGLALESSSGL	NFE2L1	116	Q14494
RGQLASPSSQSAAAS	RBM14	286	Q96PK6
PNSSSGSNGNDQLSK	RBMS2	41	Q15434
ASSSTQGARAQQAPN	TSPOAP1	1201	O95153
NGLSSSARPQGQQAG	ACACB	131	O00763
GNTSVAANATLAGAP	CD6	111	P30203
GGQQASSKLGPQASS	GATAD2A	226	Q86YP4
AASLVTSTVGQQNGS	HCFC1	1056	P51610
PLIGNGTQSNNTCSL	GLI3	806	P10071
INGTLASDLSNASPG	MED12L	1576	Q86YW9
SAQSLGVSSLNSGQI	MAN2A1	936	Q16706
ANGQSPSALQTGGSA	LATS1	381	O95835
ANLSNFNPGALSSGG	JUN	171	P05412
NLSTGQARLTSQPGA	ATAD2B	116	Q9ULI0
QGTSSISGTNNLEPL	KRT3	236	P12035
TNGSNGRNTESPAAI	LMOD2	176	Q6P5Q4
SGSSVGHNNLIPLAN	CARM1	526	Q86X55
AANVSTSGITPGQAA	ORAI1	221	Q96D31
GGQSSATDAQPGNTL	PCNX1	2216	Q96RV3
NSAAQAAIQGALNGP	NAV3	1641	Q8IVL0
PLSSSGLGSIHNSQQ	ONECUT1	181	Q9UBC0
PNPSVTGAQVSNGSN	ONECUT1	271	Q9UBC0
ISFNPQGNHLLTGSS	DAW1	351	Q8N136
SSTLSPGSAENNGNA	KANSL1	26	Q7Z3B3
GARSANQSPQSVGSS	LPIN1	431	Q14693
GNLGTPSSFNLALSQ	GOLGA6L2	131	Q8N9W4
FLLQQASGLSSPGNN	FOXP4	76	Q8IVH2
ASGLSSPGNNDSKQS	FOXP4	81	Q8IVH2
NAGVSPIGNSSNNSS	KCNK10	136	P57789
VTNGTSPAQLNGGSA	SLC9A3R2	256	Q15599
QQASAASSAAGVSGP	MED29	6	Q9NX70
ASIANSDGPTAGSQT	PHACTR2	11	O75167
NSRASPNLIGATGAN	MEF2A	231	Q02078
LQTLLSSSGAPASGQ	DDX31	531	Q9H8H2
ANLQTGSGVLNDSLS	NUP155	181	O75694
QNGSEGLAQLTSTNG	PUM1	316	Q14671
TAANGGSLNCLQTPS	PCGF2	311	P35227
ANNGSVLQGSSVASV	PON2	321	Q15165
NNGAGGTSATTCNPL	COG6	21	Q9Y2V7
STNRAAATGNASPGK	KDM1B	236	Q8NB78
GLNTTGSNSVAQVSL	FOXJ3	356	Q9UPW0
DASSGTNSNGITNPC	BORA	301	Q6PGQ7
GNLQGSLQNVSLSAP	CCDC191	501	Q8NCU4
SQDLAPNSVGAASTG	BCL9L	331	Q86UU0
LTASAPAAQAGASQG	CC2D1B	151	Q5T0F9
SQQLGLDAPNGSDSS	ABCA2	296	Q9BZC7
AGTLSGLSQTHPSQQ	LTBP2	276	Q14767
RNQSLGQSAPSLTAG	MAST2	141	Q6P0Q8
SAPLSQSGLATANGK	KANSL2	471	Q9H9L4
SLPGLAQISNQASGL	KANSL3	841	Q9P2N6
PLGNAGCQTSVASSQ	DCLRE1A	66	Q6PJP8
LLTNAVSSNGPSGND	HLTF	721	Q14527
NGQDSPASLLNISAG	CRYBG1	671	Q9Y4K1
VNGSSQQGTSNPSLG	SEH1L	326	Q96EE3
SVASNLATSALPAGN	SCAF8	741	Q9UPN6
IGGQENPNNSSASSE	SALL2	66	Q9Y467
LSLPGNSAISNVDNG	PRR14L	281	Q5THK1
NNTSGSLLNAVDGGP	nan	341	A6NNC1
QASQAQLGEAAGPAS	FOXA2	281	Q9Y261
NNLTGSSLNSAMSPG	PITX1	246	P78337
LSNSATSSGGINLNR	MEIOC	461	A2RUB1
ASGAGQTLAAAPAQL	USH2A	1456	O75445
VNGTLLPSEQAGSAS	UVRAG	596	Q9P2Y5
PAATADSGTSNGNQL	SP4	286	Q02446
ALVQSPSNQSALGAG	TNRC6C	26	Q9HCJ0
GSQPASQGLDLLSSS	SEZ6L	146	Q9BYH1
ASTGAQQPSALAALQ	SRRM2	2511	Q9UQ35
ATAATLPVGTGQNAS	TSC22D2	406	O75157
GVGNLAAPNAATSSA	NKTR	1231	P30414
GAPASLQAQNGAALA	SEC24A	11	O95486
NVSSPNTAGLRSLQG	DHODH	211	Q02127
IPNSGANSQFLNGSI	SIX4	486	Q9UIU6
VTGVPGSSLNSLNNL	PITX2	231	Q99697
TGNANTPSATLASAA	MED13	1496	Q9UHV7
NALGSQANGSVSPDS	TNS3	721	Q68CZ2
DQAGNLSSSPSALGL	TACR3	46	P29371
SSAPILELQNQGSSG	SLC35F4	106	A4IF30
GQPSSSNAGNKRLST	RACGAP1	131	Q9H0H5
INTQALQSTPGSAGN	SHC4	466	Q6S5L8
LQSTPGSAGNQRSAQ	SHC4	471	Q6S5L8
NSSASNASGAAAPTL	ZAP70	256	P43403
GNSASSIAGTAPQNG	PHC2	541	Q8IXK0
VNGNTSTPSAGAVAA	SPART	141	Q8N0X7
DAQSGSGQRSQPSSL	UBAP2	1086	Q5T6F2
GNSSVNRASPVNASA	USP42	486	Q9H9J4
SSSLGGNLPANNSSL	ZXDC	546	Q2QGD7
GTVNAAPGTVNAAAS	SPEN	2716	Q96T58
GLPGANLNSQSLAAD	SRSF11	171	Q05519
PGGRLNSSSVSNLAA	SYNGAP1	851	Q96PV0
DGLQPGANSSTLNGS	SLC26A1	151	Q9H2B4
QGNASSSTLLQGTGN	TBX18	366	O95935
GIDSPRTQSLGSNNS	STOX1	936	Q6ZVD7
NVSGNNLTISGLSPT	SP2	466	Q02086
NANNAGAASRTTSEP	VSTM2B	181	A6NLU5
QSNSATQQDPDGSGA	ZNF408	276	Q9H9D4
SAASPASENQNGNGL	NABP2	141	Q9BQ15
SSADANGNAQPSSLA	SORBS1	116	Q9BX66
GLSQAPSQIANSGSA	SAP130	41	Q9H0E3
NSGSAGLINPAATVN	SAP130	51	Q9H0E3
LPNSQELGNTSSSEG	TMEM131	1541	Q92545
SASELRQANGPLSNG	ZNF292	906	O60281
NSSASSEQGLLGRSP	SPRY1	126	O43609
SESATSNGVTNLPNG	RFX7	236	Q2KHR2
AQPIGGSLNSTTDSA	RGS14	551	O43566
TQNGTGSLPRNLAAT	PHLDB1	1011	Q86UU1
AVQSGSLALSGGPSN	PTBP3	156	O95758
GSQQISQDDQSSSPG	MYO18B	86	Q8IUG5
TPVGALQGSARNSSL	ZC2HC1C	356	Q53FD0
LAGSSAASSPNGQGL	ZNF423	1046	Q2M1K9
TSVLGGSSSAPNLQD	PPIP5K2	1066	O43314
PQLSGNLSGQSAASV	WNK1	2146	Q9H4A3
LQALPAGQVFNSSSG	TRAPPC10	1226	P48553
LAQGPGATSSAANTC	TUT7	676	Q5VYS8
APNSLVNSGAVGNSE	TUT4	1556	Q5TAX3
RATSSQGASGNEPAQ	USP40	966	Q9NVE5
LSGGPLANGENSNLS	ZNF318	1591	Q5VUA4
SSSAAGLGAVDPQLQ	TIMM8A	6	O60220
SSNGGLNPSTLNSAS	TNRC6A	351	Q8NDV7
NSKQNGSASSVAGPA	SPOCK2	221	Q92563
SSLALNSGLPNGETS	USP54	1206	Q70EL1
LPSGALTQNLNTFGN	ZAN	2481	Q9Y493
NSSGGAVATEAPNLL	ZNF628	876	Q5EBL2
GSSPSLAGSQQQLSL	KMT2D	3301	O14686
SLAASEGLSSAQPNG	KIAA1522	881	Q9P206